CN105012873A - Health-care blood-fat-lowering evening primrose oral liquid and preparation method thereof - Google Patents
Health-care blood-fat-lowering evening primrose oral liquid and preparation method thereof Download PDFInfo
- Publication number
- CN105012873A CN105012873A CN201510430210.9A CN201510430210A CN105012873A CN 105012873 A CN105012873 A CN 105012873A CN 201510430210 A CN201510430210 A CN 201510430210A CN 105012873 A CN105012873 A CN 105012873A
- Authority
- CN
- China
- Prior art keywords
- parts
- radix
- blood
- oenotherae erythrosepalae
- oral liquid
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Pending
Links
- 239000007788 liquid Substances 0.000 title claims abstract description 56
- 241000219925 Oenothera Species 0.000 title claims abstract description 10
- 235000004496 Oenothera biennis Nutrition 0.000 title claims abstract description 10
- 238000002360 preparation method Methods 0.000 title claims description 18
- 210000004369 blood Anatomy 0.000 claims abstract description 132
- 239000008280 blood Substances 0.000 claims abstract description 132
- 210000000582 semen Anatomy 0.000 claims abstract description 17
- 239000008517 radix Trichosanthis Substances 0.000 claims abstract description 13
- 239000003814 drug Substances 0.000 claims description 98
- 229940079593 drug Drugs 0.000 claims description 44
- 230000036541 health Effects 0.000 claims description 40
- 230000001603 reducing effect Effects 0.000 claims description 32
- 238000000034 method Methods 0.000 claims description 28
- 239000000706 filtrate Substances 0.000 claims description 23
- 230000008901 benefit Effects 0.000 claims description 22
- LFQSCWFLJHTTHZ-UHFFFAOYSA-N Ethanol Chemical compound CCO LFQSCWFLJHTTHZ-UHFFFAOYSA-N 0.000 claims description 20
- 241001619461 Poria <basidiomycete fungus> Species 0.000 claims description 18
- XLYOFNOQVPJJNP-UHFFFAOYSA-N water Substances O XLYOFNOQVPJJNP-UHFFFAOYSA-N 0.000 claims description 17
- 241000628997 Flos Species 0.000 claims description 16
- 238000003825 pressing Methods 0.000 claims description 15
- 230000008569 process Effects 0.000 claims description 15
- 241000180649 Panax notoginseng Species 0.000 claims description 13
- 235000003143 Panax notoginseng Nutrition 0.000 claims description 13
- 238000000605 extraction Methods 0.000 claims description 13
- 238000010438 heat treatment Methods 0.000 claims description 12
- 238000004659 sterilization and disinfection Methods 0.000 claims description 11
- 230000000844 anti-bacterial effect Effects 0.000 claims description 10
- 229920000609 methyl cellulose Polymers 0.000 claims description 9
- 239000001923 methylcellulose Substances 0.000 claims description 9
- 230000001954 sterilising effect Effects 0.000 claims description 9
- 238000000108 ultra-filtration Methods 0.000 claims description 8
- 238000001914 filtration Methods 0.000 claims description 6
- 229920001353 Dextrin Polymers 0.000 claims description 5
- 239000004375 Dextrin Substances 0.000 claims description 5
- 241000238631 Hexapoda Species 0.000 claims description 5
- VYPSYNLAJGMNEJ-UHFFFAOYSA-N Silicium dioxide Chemical compound O=[Si]=O VYPSYNLAJGMNEJ-UHFFFAOYSA-N 0.000 claims description 5
- 241000607479 Yersinia pestis Species 0.000 claims description 5
- 235000019425 dextrin Nutrition 0.000 claims description 5
- 239000000284 extract Substances 0.000 claims description 5
- 238000004321 preservation Methods 0.000 claims description 5
- 230000002829 reductive effect Effects 0.000 claims description 5
- 238000003756 stirring Methods 0.000 claims description 5
- 241000241413 Propolis Species 0.000 claims description 4
- 229940069949 propolis Drugs 0.000 claims description 4
- 239000006228 supernatant Substances 0.000 claims description 4
- 239000004615 ingredient Substances 0.000 claims description 3
- 235000011837 pasties Nutrition 0.000 claims description 3
- 238000002156 mixing Methods 0.000 claims description 2
- 238000010992 reflux Methods 0.000 claims description 2
- 239000003921 oil Substances 0.000 abstract description 48
- 208000037265 diseases, disorders, signs and symptoms Diseases 0.000 abstract description 40
- 201000010099 disease Diseases 0.000 abstract description 38
- HVYWMOMLDIMFJA-DPAQBDIFSA-N cholesterol Chemical compound C1C=C2C[C@@H](O)CC[C@]2(C)[C@@H]2[C@@H]1[C@@H]1CC[C@H]([C@H](C)CCCC(C)C)[C@@]1(C)CC2 HVYWMOMLDIMFJA-DPAQBDIFSA-N 0.000 abstract description 33
- 206010012601 diabetes mellitus Diseases 0.000 abstract description 29
- 239000000463 material Substances 0.000 abstract description 21
- VZCCETWTMQHEPK-QNEBEIHSSA-N gamma-linolenic acid Chemical compound CCCCC\C=C/C\C=C/C\C=C/CCCCC(O)=O VZCCETWTMQHEPK-QNEBEIHSSA-N 0.000 abstract description 20
- VZCCETWTMQHEPK-UHFFFAOYSA-N gamma-Linolensaeure Natural products CCCCCC=CCC=CCC=CCCCCC(O)=O VZCCETWTMQHEPK-UHFFFAOYSA-N 0.000 abstract description 19
- 235000012000 cholesterol Nutrition 0.000 abstract description 15
- 235000020664 gamma-linolenic acid Nutrition 0.000 abstract description 15
- 229960002733 gamolenic acid Drugs 0.000 abstract description 15
- 150000002632 lipids Chemical class 0.000 abstract description 14
- 208000008589 Obesity Diseases 0.000 abstract description 11
- 235000020824 obesity Nutrition 0.000 abstract description 11
- 201000003068 rheumatic fever Diseases 0.000 abstract description 11
- 206010008132 Cerebral thrombosis Diseases 0.000 abstract description 7
- 201000001429 Intracranial Thrombosis Diseases 0.000 abstract description 7
- 235000013399 edible fruits Nutrition 0.000 abstract description 7
- 201000000980 schizophrenia Diseases 0.000 abstract description 7
- 230000001105 regulatory effect Effects 0.000 abstract description 6
- OYHQOLUKZRVURQ-HZJYTTRNSA-N Linoleic acid Chemical compound CCCCC\C=C/C\C=C/CCCCCCCC(O)=O OYHQOLUKZRVURQ-HZJYTTRNSA-N 0.000 abstract description 5
- 240000008042 Zea mays Species 0.000 abstract description 5
- 235000020778 linoleic acid Nutrition 0.000 abstract description 5
- OYHQOLUKZRVURQ-IXWMQOLASA-N linoleic acid Natural products CCCCC\C=C/C\C=C\CCCCCCCC(O)=O OYHQOLUKZRVURQ-IXWMQOLASA-N 0.000 abstract description 5
- 235000008216 herbs Nutrition 0.000 abstract description 4
- 206010061216 Infarction Diseases 0.000 abstract description 3
- 244000131316 Panax pseudoginseng Species 0.000 abstract description 3
- 235000002017 Zea mays subsp mays Nutrition 0.000 abstract description 3
- VFLDPWHFBUODDF-FCXRPNKRSA-N curcumin Chemical compound C1=C(O)C(OC)=CC(\C=C\C(=O)CC(=O)\C=C\C=2C=C(OC)C(O)=CC=2)=C1 VFLDPWHFBUODDF-FCXRPNKRSA-N 0.000 abstract description 3
- 230000007574 infarction Effects 0.000 abstract description 3
- 241001106041 Lycium Species 0.000 abstract description 2
- 235000003181 Panax pseudoginseng Nutrition 0.000 abstract description 2
- 240000001341 Reynoutria japonica Species 0.000 abstract description 2
- 208000034189 Sclerosis Diseases 0.000 abstract description 2
- 240000008027 Akebia quinata Species 0.000 abstract 1
- 235000007756 Akebia quinata Nutrition 0.000 abstract 1
- 235000009051 Ambrosia paniculata var. peruviana Nutrition 0.000 abstract 1
- 235000003097 Artemisia absinthium Nutrition 0.000 abstract 1
- 240000001851 Artemisia dracunculus Species 0.000 abstract 1
- 235000017731 Artemisia dracunculus ssp. dracunculus Nutrition 0.000 abstract 1
- 235000003261 Artemisia vulgaris Nutrition 0.000 abstract 1
- 201000001320 Atherosclerosis Diseases 0.000 abstract 1
- 244000020518 Carthamus tinctorius Species 0.000 abstract 1
- 235000009917 Crataegus X brevipes Nutrition 0.000 abstract 1
- 235000013204 Crataegus X haemacarpa Nutrition 0.000 abstract 1
- 235000009685 Crataegus X maligna Nutrition 0.000 abstract 1
- 235000009444 Crataegus X rubrocarnea Nutrition 0.000 abstract 1
- 235000009486 Crataegus bullatus Nutrition 0.000 abstract 1
- 235000017181 Crataegus chrysocarpa Nutrition 0.000 abstract 1
- 235000009682 Crataegus limnophila Nutrition 0.000 abstract 1
- 240000000171 Crataegus monogyna Species 0.000 abstract 1
- 235000004423 Crataegus monogyna Nutrition 0.000 abstract 1
- 235000002313 Crataegus paludosa Nutrition 0.000 abstract 1
- 235000009840 Crataegus x incaedua Nutrition 0.000 abstract 1
- 235000014375 Curcuma Nutrition 0.000 abstract 1
- 244000164480 Curcuma aromatica Species 0.000 abstract 1
- 240000006509 Gynostemma pentaphyllum Species 0.000 abstract 1
- 235000002956 Gynostemma pentaphyllum Nutrition 0.000 abstract 1
- 241000830535 Ligustrum lucidum Species 0.000 abstract 1
- 244000170916 Paeonia officinalis Species 0.000 abstract 1
- 235000006484 Paeonia officinalis Nutrition 0.000 abstract 1
- 244000197580 Poria cocos Species 0.000 abstract 1
- 235000008599 Poria cocos Nutrition 0.000 abstract 1
- 235000018167 Reynoutria japonica Nutrition 0.000 abstract 1
- 244000153955 Reynoutria sachalinensis Species 0.000 abstract 1
- 235000003202 Reynoutria sachalinensis Nutrition 0.000 abstract 1
- 235000017276 Salvia Nutrition 0.000 abstract 1
- 240000007164 Salvia officinalis Species 0.000 abstract 1
- 235000005824 Zea mays ssp. parviglumis Nutrition 0.000 abstract 1
- 239000001138 artemisia absinthium Substances 0.000 abstract 1
- 235000005822 corn Nutrition 0.000 abstract 1
- 235000008524 evening primrose extract Nutrition 0.000 abstract 1
- 229940089020 evening primrose oil Drugs 0.000 abstract 1
- 239000010475 evening primrose oil Substances 0.000 abstract 1
- KDYFGRWQOYBRFD-UHFFFAOYSA-N succinic acid Chemical compound OC(=O)CCC(O)=O KDYFGRWQOYBRFD-UHFFFAOYSA-N 0.000 abstract 1
- 230000000694 effects Effects 0.000 description 58
- 235000019198 oils Nutrition 0.000 description 47
- 235000019197 fats Nutrition 0.000 description 45
- 208000002193 Pain Diseases 0.000 description 26
- 201000005577 familial hyperlipidemia Diseases 0.000 description 24
- 208000031226 Hyperlipidaemia Diseases 0.000 description 21
- 230000001737 promoting effect Effects 0.000 description 20
- 230000006870 function Effects 0.000 description 17
- 235000005911 diet Nutrition 0.000 description 16
- 235000014113 dietary fatty acids Nutrition 0.000 description 16
- 239000000194 fatty acid Substances 0.000 description 16
- 229930195729 fatty acid Natural products 0.000 description 16
- 150000004665 fatty acids Chemical class 0.000 description 16
- 241001465754 Metazoa Species 0.000 description 15
- 239000000203 mixture Substances 0.000 description 15
- 241000699670 Mus sp. Species 0.000 description 14
- 235000013305 food Nutrition 0.000 description 14
- 210000004185 liver Anatomy 0.000 description 14
- 208000004880 Polyuria Diseases 0.000 description 13
- 230000037396 body weight Effects 0.000 description 13
- 230000037213 diet Effects 0.000 description 13
- 230000035619 diuresis Effects 0.000 description 13
- 238000012360 testing method Methods 0.000 description 13
- 230000017531 blood circulation Effects 0.000 description 12
- 206010020772 Hypertension Diseases 0.000 description 11
- 210000000952 spleen Anatomy 0.000 description 11
- 208000006820 Arthralgia Diseases 0.000 description 10
- 210000004204 blood vessel Anatomy 0.000 description 10
- 201000006417 multiple sclerosis Diseases 0.000 description 10
- UFTFJSFQGQCHQW-UHFFFAOYSA-N triformin Chemical compound O=COCC(OC=O)COC=O UFTFJSFQGQCHQW-UHFFFAOYSA-N 0.000 description 10
- 201000000736 Amenorrhea Diseases 0.000 description 9
- 206010001928 Amenorrhoea Diseases 0.000 description 9
- 206010007247 Carbuncle Diseases 0.000 description 9
- WQZGKKKJIJFFOK-GASJEMHNSA-N Glucose Natural products OC[C@H]1OC(O)[C@H](O)[C@@H](O)[C@@H]1O WQZGKKKJIJFFOK-GASJEMHNSA-N 0.000 description 9
- 208000035150 Hypercholesterolemia Diseases 0.000 description 9
- 208000027418 Wounds and injury Diseases 0.000 description 9
- 231100000540 amenorrhea Toxicity 0.000 description 9
- 230000036772 blood pressure Effects 0.000 description 9
- 239000008103 glucose Substances 0.000 description 9
- 150000003180 prostaglandins Chemical class 0.000 description 9
- 206010062717 Increased upper airway secretion Diseases 0.000 description 8
- 241000700159 Rattus Species 0.000 description 8
- 206010042674 Swelling Diseases 0.000 description 8
- 235000009508 confectionery Nutrition 0.000 description 8
- 210000002216 heart Anatomy 0.000 description 8
- 210000003734 kidney Anatomy 0.000 description 8
- 208000026435 phlegm Diseases 0.000 description 8
- 230000008961 swelling Effects 0.000 description 8
- 235000015112 vegetable and seed oil Nutrition 0.000 description 8
- OYHQOLUKZRVURQ-NTGFUMLPSA-N (9Z,12Z)-9,10,12,13-tetratritiooctadeca-9,12-dienoic acid Chemical compound C(CCCCCCC\C(=C(/C\C(=C(/CCCCC)\[3H])\[3H])\[3H])\[3H])(=O)O OYHQOLUKZRVURQ-NTGFUMLPSA-N 0.000 description 7
- 208000024172 Cardiovascular disease Diseases 0.000 description 7
- 206010023126 Jaundice Diseases 0.000 description 7
- 206010037660 Pyrexia Diseases 0.000 description 7
- 206010052428 Wound Diseases 0.000 description 7
- 208000031971 Yin Deficiency Diseases 0.000 description 7
- 210000001015 abdomen Anatomy 0.000 description 7
- 230000001093 anti-cancer Effects 0.000 description 7
- 208000029078 coronary artery disease Diseases 0.000 description 7
- 238000004519 manufacturing process Methods 0.000 description 7
- 235000015097 nutrients Nutrition 0.000 description 7
- 230000001717 pathogenic effect Effects 0.000 description 7
- 230000002265 prevention Effects 0.000 description 7
- 238000011160 research Methods 0.000 description 7
- 210000003491 skin Anatomy 0.000 description 7
- 239000000243 solution Substances 0.000 description 7
- 206010010774 Constipation Diseases 0.000 description 6
- 206010011224 Cough Diseases 0.000 description 6
- 208000013738 Sleep Initiation and Maintenance disease Diseases 0.000 description 6
- 244000269722 Thea sinensis Species 0.000 description 6
- 210000001124 body fluid Anatomy 0.000 description 6
- 239000010839 body fluid Substances 0.000 description 6
- 229940098330 gamma linoleic acid Drugs 0.000 description 6
- 241000411851 herbal medicine Species 0.000 description 6
- 201000001421 hyperglycemia Diseases 0.000 description 6
- 238000001727 in vivo Methods 0.000 description 6
- 208000014674 injury Diseases 0.000 description 6
- 206010022437 insomnia Diseases 0.000 description 6
- 210000004072 lung Anatomy 0.000 description 6
- 238000007670 refining Methods 0.000 description 6
- 230000035922 thirst Effects 0.000 description 6
- 206010012735 Diarrhoea Diseases 0.000 description 5
- 206010013935 Dysmenorrhoea Diseases 0.000 description 5
- 208000019255 Menstrual disease Diseases 0.000 description 5
- 230000003110 anti-inflammatory effect Effects 0.000 description 5
- 201000008937 atopic dermatitis Diseases 0.000 description 5
- 210000004556 brain Anatomy 0.000 description 5
- 208000026106 cerebrovascular disease Diseases 0.000 description 5
- 230000034994 death Effects 0.000 description 5
- 230000000916 dilatatory effect Effects 0.000 description 5
- 230000003203 everyday effect Effects 0.000 description 5
- 230000002496 gastric effect Effects 0.000 description 5
- 229940088597 hormone Drugs 0.000 description 5
- 239000005556 hormone Substances 0.000 description 5
- 230000033001 locomotion Effects 0.000 description 5
- 230000035764 nutrition Effects 0.000 description 5
- 235000016709 nutrition Nutrition 0.000 description 5
- 244000052769 pathogen Species 0.000 description 5
- 231100000614 poison Toxicity 0.000 description 5
- 210000001519 tissue Anatomy 0.000 description 5
- 235000013311 vegetables Nutrition 0.000 description 5
- 206010003210 Arteriosclerosis Diseases 0.000 description 4
- 208000034656 Contusions Diseases 0.000 description 4
- 206010012438 Dermatitis atopic Diseases 0.000 description 4
- 208000004930 Fatty Liver Diseases 0.000 description 4
- 208000015220 Febrile disease Diseases 0.000 description 4
- 206010019708 Hepatic steatosis Diseases 0.000 description 4
- 206010061218 Inflammation Diseases 0.000 description 4
- 206010030113 Oedema Diseases 0.000 description 4
- 238000010521 absorption reaction Methods 0.000 description 4
- 238000009825 accumulation Methods 0.000 description 4
- 230000003213 activating effect Effects 0.000 description 4
- 208000011775 arteriosclerosis disease Diseases 0.000 description 4
- 230000015572 biosynthetic process Effects 0.000 description 4
- 210000000481 breast Anatomy 0.000 description 4
- 208000034526 bruise Diseases 0.000 description 4
- 230000004087 circulation Effects 0.000 description 4
- 230000006378 damage Effects 0.000 description 4
- 208000001848 dysentery Diseases 0.000 description 4
- 206010013990 dysuria Diseases 0.000 description 4
- 238000005516 engineering process Methods 0.000 description 4
- 208000001780 epistaxis Diseases 0.000 description 4
- 238000002474 experimental method Methods 0.000 description 4
- 208000010706 fatty liver disease Diseases 0.000 description 4
- 210000000232 gallbladder Anatomy 0.000 description 4
- 239000007789 gas Substances 0.000 description 4
- 230000001077 hypotensive effect Effects 0.000 description 4
- 230000004054 inflammatory process Effects 0.000 description 4
- NOESYZHRGYRDHS-UHFFFAOYSA-N insulin Chemical compound N1C(=O)C(NC(=O)C(CCC(N)=O)NC(=O)C(CCC(O)=O)NC(=O)C(C(C)C)NC(=O)C(NC(=O)CN)C(C)CC)CSSCC(C(NC(CO)C(=O)NC(CC(C)C)C(=O)NC(CC=2C=CC(O)=CC=2)C(=O)NC(CCC(N)=O)C(=O)NC(CC(C)C)C(=O)NC(CCC(O)=O)C(=O)NC(CC(N)=O)C(=O)NC(CC=2C=CC(O)=CC=2)C(=O)NC(CSSCC(NC(=O)C(C(C)C)NC(=O)C(CC(C)C)NC(=O)C(CC=2C=CC(O)=CC=2)NC(=O)C(CC(C)C)NC(=O)C(C)NC(=O)C(CCC(O)=O)NC(=O)C(C(C)C)NC(=O)C(CC(C)C)NC(=O)C(CC=2NC=NC=2)NC(=O)C(CO)NC(=O)CNC2=O)C(=O)NCC(=O)NC(CCC(O)=O)C(=O)NC(CCCNC(N)=N)C(=O)NCC(=O)NC(CC=3C=CC=CC=3)C(=O)NC(CC=3C=CC=CC=3)C(=O)NC(CC=3C=CC(O)=CC=3)C(=O)NC(C(C)O)C(=O)N3C(CCC3)C(=O)NC(CCCCN)C(=O)NC(C)C(O)=O)C(=O)NC(CC(N)=O)C(O)=O)=O)NC(=O)C(C(C)CC)NC(=O)C(CO)NC(=O)C(C(C)O)NC(=O)C1CSSCC2NC(=O)C(CC(C)C)NC(=O)C(NC(=O)C(CCC(N)=O)NC(=O)C(CC(N)=O)NC(=O)C(NC(=O)C(N)CC=1C=CC=CC=1)C(C)C)CC1=CN=CN1 NOESYZHRGYRDHS-UHFFFAOYSA-N 0.000 description 4
- 230000007774 longterm Effects 0.000 description 4
- 239000002398 materia medica Substances 0.000 description 4
- 230000005906 menstruation Effects 0.000 description 4
- 239000002574 poison Substances 0.000 description 4
- 239000000047 product Substances 0.000 description 4
- 230000001681 protective effect Effects 0.000 description 4
- 102000004169 proteins and genes Human genes 0.000 description 4
- 108090000623 proteins and genes Proteins 0.000 description 4
- 238000010791 quenching Methods 0.000 description 4
- 231100000240 steatosis hepatitis Toxicity 0.000 description 4
- 150000003431 steroids Chemical class 0.000 description 4
- 210000002784 stomach Anatomy 0.000 description 4
- 231100000331 toxic Toxicity 0.000 description 4
- 230000002588 toxic effect Effects 0.000 description 4
- 230000002936 tranquilizing effect Effects 0.000 description 4
- 230000008736 traumatic injury Effects 0.000 description 4
- 206010000087 Abdominal pain upper Diseases 0.000 description 3
- 201000004624 Dermatitis Diseases 0.000 description 3
- 208000005171 Dysmenorrhea Diseases 0.000 description 3
- 241000196324 Embryophyta Species 0.000 description 3
- 206010019909 Hernia Diseases 0.000 description 3
- 108010007622 LDL Lipoproteins Proteins 0.000 description 3
- 102000007330 LDL Lipoproteins Human genes 0.000 description 3
- 206010027514 Metrorrhagia Diseases 0.000 description 3
- 208000025747 Rheumatic disease Diseases 0.000 description 3
- FAPWRFPIFSIZLT-UHFFFAOYSA-M Sodium chloride Chemical compound [Na+].[Cl-] FAPWRFPIFSIZLT-UHFFFAOYSA-M 0.000 description 3
- 206010043458 Thirst Diseases 0.000 description 3
- 241000700605 Viruses Species 0.000 description 3
- 239000002253 acid Substances 0.000 description 3
- 210000000577 adipose tissue Anatomy 0.000 description 3
- 208000006673 asthma Diseases 0.000 description 3
- 208000010668 atopic eczema Diseases 0.000 description 3
- 230000009286 beneficial effect Effects 0.000 description 3
- 210000004027 cell Anatomy 0.000 description 3
- 239000003153 chemical reaction reagent Substances 0.000 description 3
- KRKNYBCHXYNGOX-UHFFFAOYSA-N citric acid Chemical compound OC(=O)CC(O)(C(O)=O)CC(O)=O KRKNYBCHXYNGOX-UHFFFAOYSA-N 0.000 description 3
- 230000001276 controlling effect Effects 0.000 description 3
- 238000001816 cooling Methods 0.000 description 3
- 230000007812 deficiency Effects 0.000 description 3
- 238000011161 development Methods 0.000 description 3
- 230000018109 developmental process Effects 0.000 description 3
- 238000003745 diagnosis Methods 0.000 description 3
- 230000000378 dietary effect Effects 0.000 description 3
- 239000012153 distilled water Substances 0.000 description 3
- 238000009826 distribution Methods 0.000 description 3
- 239000002934 diuretic Substances 0.000 description 3
- 230000001882 diuretic effect Effects 0.000 description 3
- 208000002173 dizziness Diseases 0.000 description 3
- 230000000857 drug effect Effects 0.000 description 3
- 230000002708 enhancing effect Effects 0.000 description 3
- 230000004438 eyesight Effects 0.000 description 3
- 229930003935 flavonoid Natural products 0.000 description 3
- 150000002215 flavonoids Chemical class 0.000 description 3
- 235000017173 flavonoids Nutrition 0.000 description 3
- 206010061989 glomerulosclerosis Diseases 0.000 description 3
- 230000012010 growth Effects 0.000 description 3
- 230000002440 hepatic effect Effects 0.000 description 3
- 235000003642 hunger Nutrition 0.000 description 3
- 208000015181 infectious disease Diseases 0.000 description 3
- 230000000968 intestinal effect Effects 0.000 description 3
- 230000003908 liver function Effects 0.000 description 3
- XZWYZXLIPXDOLR-UHFFFAOYSA-N metformin hydrochloride Natural products CN(C)C(=N)NC(N)=N XZWYZXLIPXDOLR-UHFFFAOYSA-N 0.000 description 3
- 230000001047 pyretic effect Effects 0.000 description 3
- 230000000552 rheumatic effect Effects 0.000 description 3
- 210000002966 serum Anatomy 0.000 description 3
- 206010040872 skin infection Diseases 0.000 description 3
- 235000014347 soups Nutrition 0.000 description 3
- 208000024891 symptom Diseases 0.000 description 3
- 238000003786 synthesis reaction Methods 0.000 description 3
- 235000019640 taste Nutrition 0.000 description 3
- 210000002700 urine Anatomy 0.000 description 3
- 230000002087 whitening effect Effects 0.000 description 3
- MIJYXULNPSFWEK-GTOFXWBISA-N 3beta-hydroxyolean-12-en-28-oic acid Chemical compound C1C[C@H](O)C(C)(C)[C@@H]2CC[C@@]3(C)[C@]4(C)CC[C@@]5(C(O)=O)CCC(C)(C)C[C@H]5C4=CC[C@@H]3[C@]21C MIJYXULNPSFWEK-GTOFXWBISA-N 0.000 description 2
- 208000004611 Abdominal Obesity Diseases 0.000 description 2
- 208000004998 Abdominal Pain Diseases 0.000 description 2
- 206010000077 Abdominal mass Diseases 0.000 description 2
- 201000004384 Alopecia Diseases 0.000 description 2
- 206010002383 Angina Pectoris Diseases 0.000 description 2
- CIWBSHSKHKDKBQ-JLAZNSOCSA-N Ascorbic acid Chemical compound OC[C@H](O)[C@H]1OC(=O)C(O)=C1O CIWBSHSKHKDKBQ-JLAZNSOCSA-N 0.000 description 2
- 241000894006 Bacteria Species 0.000 description 2
- 206010065941 Central obesity Diseases 0.000 description 2
- 206010008190 Cerebrovascular accident Diseases 0.000 description 2
- 229920000742 Cotton Polymers 0.000 description 2
- 206010013954 Dysphoria Diseases 0.000 description 2
- 108090000790 Enzymes Proteins 0.000 description 2
- 102000004190 Enzymes Human genes 0.000 description 2
- JKLISIRFYWXLQG-UHFFFAOYSA-N Epioleonolsaeure Natural products C1CC(O)C(C)(C)C2CCC3(C)C4(C)CCC5(C(O)=O)CCC(C)(C)CC5C4CCC3C21C JKLISIRFYWXLQG-UHFFFAOYSA-N 0.000 description 2
- 241000287828 Gallus gallus Species 0.000 description 2
- PEDCQBHIVMGVHV-UHFFFAOYSA-N Glycerine Chemical compound OCC(O)CO PEDCQBHIVMGVHV-UHFFFAOYSA-N 0.000 description 2
- 108010010234 HDL Lipoproteins Proteins 0.000 description 2
- 102000015779 HDL Lipoproteins Human genes 0.000 description 2
- 206010019233 Headaches Diseases 0.000 description 2
- 206010021118 Hypotonia Diseases 0.000 description 2
- 102000004877 Insulin Human genes 0.000 description 2
- 108090001061 Insulin Proteins 0.000 description 2
- 206010022998 Irritability Diseases 0.000 description 2
- 108010028554 LDL Cholesterol Proteins 0.000 description 2
- 108090001030 Lipoproteins Proteins 0.000 description 2
- 102000004895 Lipoproteins Human genes 0.000 description 2
- 208000015924 Lithiasis Diseases 0.000 description 2
- 235000015468 Lycium chinense Nutrition 0.000 description 2
- 244000241872 Lycium chinense Species 0.000 description 2
- 208000002720 Malnutrition Diseases 0.000 description 2
- 241000699666 Mus <mouse, genus> Species 0.000 description 2
- 206010029164 Nephrotic syndrome Diseases 0.000 description 2
- YBRJHZPWOMJYKQ-UHFFFAOYSA-N Oleanolic acid Natural products CC1(C)CC2C3=CCC4C5(C)CCC(O)C(C)(C)C5CCC4(C)C3(C)CCC2(C1)C(=O)O YBRJHZPWOMJYKQ-UHFFFAOYSA-N 0.000 description 2
- MIJYXULNPSFWEK-UHFFFAOYSA-N Oleanolinsaeure Natural products C1CC(O)C(C)(C)C2CCC3(C)C4(C)CCC5(C(O)=O)CCC(C)(C)CC5C4=CCC3C21C MIJYXULNPSFWEK-UHFFFAOYSA-N 0.000 description 2
- 206010068319 Oropharyngeal pain Diseases 0.000 description 2
- 206010033645 Pancreatitis Diseases 0.000 description 2
- 201000007100 Pharyngitis Diseases 0.000 description 2
- 241000222640 Polyporus Species 0.000 description 2
- 208000003251 Pruritus Diseases 0.000 description 2
- 208000001431 Psychomotor Agitation Diseases 0.000 description 2
- 206010038743 Restlessness Diseases 0.000 description 2
- -1 Resveratrol glycoside Chemical class 0.000 description 2
- 206010040943 Skin Ulcer Diseases 0.000 description 2
- 206010041349 Somnolence Diseases 0.000 description 2
- 208000006011 Stroke Diseases 0.000 description 2
- 208000007271 Substance Withdrawal Syndrome Diseases 0.000 description 2
- 206010053615 Thermal burn Diseases 0.000 description 2
- 208000007536 Thrombosis Diseases 0.000 description 2
- 208000009205 Tinnitus Diseases 0.000 description 2
- 206010047531 Visual acuity reduced Diseases 0.000 description 2
- 235000007244 Zea mays Nutrition 0.000 description 2
- 235000016383 Zea mays subsp huehuetenangensis Nutrition 0.000 description 2
- 230000009471 action Effects 0.000 description 2
- 230000032683 aging Effects 0.000 description 2
- 231100000360 alopecia Toxicity 0.000 description 2
- 230000000202 analgesic effect Effects 0.000 description 2
- 238000010171 animal model Methods 0.000 description 2
- 230000001754 anti-pyretic effect Effects 0.000 description 2
- 239000003963 antioxidant agent Substances 0.000 description 2
- 235000006708 antioxidants Nutrition 0.000 description 2
- 206010003549 asthenia Diseases 0.000 description 2
- 230000003143 atherosclerotic effect Effects 0.000 description 2
- WQZGKKKJIJFFOK-VFUOTHLCSA-N beta-D-glucose Chemical compound OC[C@H]1O[C@@H](O)[C@H](O)[C@@H](O)[C@@H]1O WQZGKKKJIJFFOK-VFUOTHLCSA-N 0.000 description 2
- 230000033228 biological regulation Effects 0.000 description 2
- 230000036760 body temperature Effects 0.000 description 2
- RYYVLZVUVIJVGH-UHFFFAOYSA-N caffeine Chemical compound CN1C(=O)N(C)C(=O)C2=C1N=CN2C RYYVLZVUVIJVGH-UHFFFAOYSA-N 0.000 description 2
- 230000001914 calming effect Effects 0.000 description 2
- 150000001720 carbohydrates Chemical class 0.000 description 2
- 235000013339 cereals Nutrition 0.000 description 2
- 206010008118 cerebral infarction Diseases 0.000 description 2
- 238000006243 chemical reaction Methods 0.000 description 2
- 239000003795 chemical substances by application Substances 0.000 description 2
- 210000000038 chest Anatomy 0.000 description 2
- 150000001840 cholesterol esters Chemical class 0.000 description 2
- 230000001684 chronic effect Effects 0.000 description 2
- 230000015271 coagulation Effects 0.000 description 2
- 238000005345 coagulation Methods 0.000 description 2
- 230000027326 copulation Effects 0.000 description 2
- 229940089639 cornsilk Drugs 0.000 description 2
- 230000007850 degeneration Effects 0.000 description 2
- 208000035475 disorder Diseases 0.000 description 2
- 235000005686 eating Nutrition 0.000 description 2
- 230000007937 eating Effects 0.000 description 2
- 235000006694 eating habits Nutrition 0.000 description 2
- 230000002526 effect on cardiovascular system Effects 0.000 description 2
- 210000003743 erythrocyte Anatomy 0.000 description 2
- 230000005284 excitation Effects 0.000 description 2
- 208000017561 flaccidity Diseases 0.000 description 2
- 239000000796 flavoring agent Substances 0.000 description 2
- 235000019634 flavors Nutrition 0.000 description 2
- 210000001035 gastrointestinal tract Anatomy 0.000 description 2
- 238000003304 gavage Methods 0.000 description 2
- 150000004676 glycans Chemical class 0.000 description 2
- 231100000869 headache Toxicity 0.000 description 2
- 208000035861 hematochezia Diseases 0.000 description 2
- 208000006454 hepatitis Diseases 0.000 description 2
- 230000002218 hypoglycaemic effect Effects 0.000 description 2
- 230000036737 immune function Effects 0.000 description 2
- 230000036039 immunity Effects 0.000 description 2
- 230000001939 inductive effect Effects 0.000 description 2
- 230000002757 inflammatory effect Effects 0.000 description 2
- 238000002347 injection Methods 0.000 description 2
- 239000007924 injection Substances 0.000 description 2
- 229910052500 inorganic mineral Inorganic materials 0.000 description 2
- 229940125396 insulin Drugs 0.000 description 2
- 239000008929 jingui shenqi Substances 0.000 description 2
- 230000003907 kidney function Effects 0.000 description 2
- 210000000265 leukocyte Anatomy 0.000 description 2
- 230000037356 lipid metabolism Effects 0.000 description 2
- 210000005229 liver cell Anatomy 0.000 description 2
- 230000014759 maintenance of location Effects 0.000 description 2
- 235000009973 maize Nutrition 0.000 description 2
- 230000003211 malignant effect Effects 0.000 description 2
- 230000001071 malnutrition Effects 0.000 description 2
- 235000000824 malnutrition Nutrition 0.000 description 2
- 239000012567 medical material Substances 0.000 description 2
- 230000002175 menstrual effect Effects 0.000 description 2
- 230000003821 menstrual periods Effects 0.000 description 2
- 230000004060 metabolic process Effects 0.000 description 2
- OETHQSJEHLVLGH-UHFFFAOYSA-N metformin hydrochloride Chemical compound Cl.CN(C)C(=N)N=C(N)N OETHQSJEHLVLGH-UHFFFAOYSA-N 0.000 description 2
- 235000013336 milk Nutrition 0.000 description 2
- 239000008267 milk Substances 0.000 description 2
- 210000004080 milk Anatomy 0.000 description 2
- 239000011707 mineral Substances 0.000 description 2
- 235000010755 mineral Nutrition 0.000 description 2
- 238000010172 mouse model Methods 0.000 description 2
- 210000004165 myocardium Anatomy 0.000 description 2
- 231100000957 no side effect Toxicity 0.000 description 2
- 208000015380 nutritional deficiency disease Diseases 0.000 description 2
- 229940100243 oleanolic acid Drugs 0.000 description 2
- 210000000056 organ Anatomy 0.000 description 2
- 230000001575 pathological effect Effects 0.000 description 2
- 150000003904 phospholipids Chemical class 0.000 description 2
- 210000002381 plasma Anatomy 0.000 description 2
- 239000011505 plaster Substances 0.000 description 2
- 229920001282 polysaccharide Polymers 0.000 description 2
- 239000005017 polysaccharide Substances 0.000 description 2
- 239000013641 positive control Substances 0.000 description 2
- 230000003389 potentiating effect Effects 0.000 description 2
- 238000012545 processing Methods 0.000 description 2
- HZLWUYJLOIAQFC-UHFFFAOYSA-N prosapogenin PS-A Natural products C12CC(C)(C)CCC2(C(O)=O)CCC(C2(CCC3C4(C)C)C)(C)C1=CCC2C3(C)CCC4OC1OCC(O)C(O)C1O HZLWUYJLOIAQFC-UHFFFAOYSA-N 0.000 description 2
- 150000003254 radicals Chemical class 0.000 description 2
- 230000008929 regeneration Effects 0.000 description 2
- 238000011069 regeneration method Methods 0.000 description 2
- 230000001850 reproductive effect Effects 0.000 description 2
- 229930182490 saponin Natural products 0.000 description 2
- 150000007949 saponins Chemical class 0.000 description 2
- 235000017709 saponins Nutrition 0.000 description 2
- 230000035807 sensation Effects 0.000 description 2
- 235000019615 sensations Nutrition 0.000 description 2
- 230000001568 sexual effect Effects 0.000 description 2
- 231100000019 skin ulcer Toxicity 0.000 description 2
- 230000000391 smoking effect Effects 0.000 description 2
- 238000005728 strengthening Methods 0.000 description 2
- 239000000126 substance Substances 0.000 description 2
- 235000021147 sweet food Nutrition 0.000 description 2
- 206010042772 syncope Diseases 0.000 description 2
- 208000011580 syndromic disease Diseases 0.000 description 2
- 238000010998 test method Methods 0.000 description 2
- VZGDMQKNWNREIO-UHFFFAOYSA-N tetrachloromethane Chemical compound ClC(Cl)(Cl)Cl VZGDMQKNWNREIO-UHFFFAOYSA-N 0.000 description 2
- ZFXYFBGIUFBOJW-UHFFFAOYSA-N theophylline Chemical compound O=C1N(C)C(=O)N(C)C2=C1NC=N2 ZFXYFBGIUFBOJW-UHFFFAOYSA-N 0.000 description 2
- 238000002560 therapeutic procedure Methods 0.000 description 2
- 231100000886 tinnitus Toxicity 0.000 description 2
- 231100000419 toxicity Toxicity 0.000 description 2
- 230000001988 toxicity Effects 0.000 description 2
- 210000003932 urinary bladder Anatomy 0.000 description 2
- 239000008158 vegetable oil Substances 0.000 description 2
- 239000001231 zea mays silk Substances 0.000 description 2
- PFTAWBLQPZVEMU-DZGCQCFKSA-N (+)-catechin Chemical compound C1([C@H]2OC3=CC(O)=CC(O)=C3C[C@@H]2O)=CC=C(O)C(O)=C1 PFTAWBLQPZVEMU-DZGCQCFKSA-N 0.000 description 1
- SNICXCGAKADSCV-JTQLQIEISA-N (-)-Nicotine Chemical compound CN1CCC[C@H]1C1=CC=CN=C1 SNICXCGAKADSCV-JTQLQIEISA-N 0.000 description 1
- SFLSHLFXELFNJZ-QMMMGPOBSA-N (-)-norepinephrine Chemical compound NC[C@H](O)C1=CC=C(O)C(O)=C1 SFLSHLFXELFNJZ-QMMMGPOBSA-N 0.000 description 1
- GMVPRGQOIOIIMI-UHFFFAOYSA-N (8R,11R,12R,13E,15S)-11,15-Dihydroxy-9-oxo-13-prostenoic acid Natural products CCCCCC(O)C=CC1C(O)CC(=O)C1CCCCCCC(O)=O GMVPRGQOIOIIMI-UHFFFAOYSA-N 0.000 description 1
- UCTWMZQNUQWSLP-VIFPVBQESA-N (R)-adrenaline Chemical compound CNC[C@H](O)C1=CC=C(O)C(O)=C1 UCTWMZQNUQWSLP-VIFPVBQESA-N 0.000 description 1
- 229930182837 (R)-adrenaline Natural products 0.000 description 1
- HTIQEAQVCYTUBX-KRWDZBQOSA-N (S)-amlodipine Chemical compound CCOC(=O)C1=C(COCCN)NC(C)=C(C(=O)OC)[C@@H]1C1=CC=CC=C1Cl HTIQEAQVCYTUBX-KRWDZBQOSA-N 0.000 description 1
- BJEPYKJPYRNKOW-REOHCLBHSA-N (S)-malic acid Chemical compound OC(=O)[C@@H](O)CC(O)=O BJEPYKJPYRNKOW-REOHCLBHSA-N 0.000 description 1
- JKBKMIKSUBLJRK-UHFFFAOYSA-N 2-propylsulfanylpyrimidine Chemical compound CCCSC1=NC=CC=N1 JKBKMIKSUBLJRK-UHFFFAOYSA-N 0.000 description 1
- 206010063409 Acarodermatitis Diseases 0.000 description 1
- 208000019901 Anxiety disease Diseases 0.000 description 1
- 244000252230 Artemisia stelleriana Species 0.000 description 1
- 206010003211 Arteriosclerosis coronary artery Diseases 0.000 description 1
- 206010003694 Atrophy Diseases 0.000 description 1
- 241000221377 Auricularia Species 0.000 description 1
- OYPRJOBELJOOCE-UHFFFAOYSA-N Calcium Chemical compound [Ca] OYPRJOBELJOOCE-UHFFFAOYSA-N 0.000 description 1
- 206010065559 Cerebral arteriosclerosis Diseases 0.000 description 1
- 206010008111 Cerebral haemorrhage Diseases 0.000 description 1
- 208000017667 Chronic Disease Diseases 0.000 description 1
- 206010008909 Chronic Hepatitis Diseases 0.000 description 1
- 241000756943 Codonopsis Species 0.000 description 1
- 102000008186 Collagen Human genes 0.000 description 1
- 108010035532 Collagen Proteins 0.000 description 1
- 206010010071 Coma Diseases 0.000 description 1
- 208000035473 Communicable disease Diseases 0.000 description 1
- 206010051625 Conjunctival hyperaemia Diseases 0.000 description 1
- ZZZCUOFIHGPKAK-UHFFFAOYSA-N D-erythro-ascorbic acid Natural products OCC1OC(=O)C(O)=C1O ZZZCUOFIHGPKAK-UHFFFAOYSA-N 0.000 description 1
- 206010012218 Delirium Diseases 0.000 description 1
- 206010012434 Dermatitis allergic Diseases 0.000 description 1
- FEWJPZIEWOKRBE-JCYAYHJZSA-N Dextrotartaric acid Chemical compound OC(=O)[C@H](O)[C@@H](O)C(O)=O FEWJPZIEWOKRBE-JCYAYHJZSA-N 0.000 description 1
- MYMOFIZGZYHOMD-UHFFFAOYSA-N Dioxygen Chemical compound O=O MYMOFIZGZYHOMD-UHFFFAOYSA-N 0.000 description 1
- 241001050985 Disco Species 0.000 description 1
- 206010052804 Drug tolerance Diseases 0.000 description 1
- 208000032928 Dyslipidaemia Diseases 0.000 description 1
- 208000000059 Dyspnea Diseases 0.000 description 1
- 206010013975 Dyspnoeas Diseases 0.000 description 1
- 102000002322 Egg Proteins Human genes 0.000 description 1
- 108010000912 Egg Proteins Proteins 0.000 description 1
- 208000005189 Embolism Diseases 0.000 description 1
- 102000009123 Fibrin Human genes 0.000 description 1
- 108010073385 Fibrin Proteins 0.000 description 1
- BWGVNKXGVNDBDI-UHFFFAOYSA-N Fibrin monomer Chemical compound CNC(=O)CNC(=O)CN BWGVNKXGVNDBDI-UHFFFAOYSA-N 0.000 description 1
- 206010016807 Fluid retention Diseases 0.000 description 1
- 206010055690 Foetal death Diseases 0.000 description 1
- 206010017553 Furuncle Diseases 0.000 description 1
- 240000004859 Gamochaeta purpurea Species 0.000 description 1
- 208000005577 Gastroenteritis Diseases 0.000 description 1
- 229920002527 Glycogen Polymers 0.000 description 1
- 108010023302 HDL Cholesterol Proteins 0.000 description 1
- 208000034507 Haematemesis Diseases 0.000 description 1
- 102000001554 Hemoglobins Human genes 0.000 description 1
- 108010054147 Hemoglobins Proteins 0.000 description 1
- 208000000616 Hemoptysis Diseases 0.000 description 1
- 101000852815 Homo sapiens Insulin receptor Proteins 0.000 description 1
- 208000008454 Hyperhidrosis Diseases 0.000 description 1
- 206010020852 Hypertonia Diseases 0.000 description 1
- 206010020880 Hypertrophy Diseases 0.000 description 1
- 102100036721 Insulin receptor Human genes 0.000 description 1
- 206010061245 Internal injury Diseases 0.000 description 1
- XEEYBQQBJWHFJM-UHFFFAOYSA-N Iron Chemical compound [Fe] XEEYBQQBJWHFJM-UHFFFAOYSA-N 0.000 description 1
- LPHGQDQBBGAPDZ-UHFFFAOYSA-N Isocaffeine Natural products CN1C(=O)N(C)C(=O)C2=C1N(C)C=N2 LPHGQDQBBGAPDZ-UHFFFAOYSA-N 0.000 description 1
- 238000012449 Kunming mouse Methods 0.000 description 1
- 240000000599 Lentinula edodes Species 0.000 description 1
- 235000001715 Lentinula edodes Nutrition 0.000 description 1
- 208000017170 Lipid metabolism disease Diseases 0.000 description 1
- UPYKUZBSLRQECL-UKMVMLAPSA-N Lycopene Natural products CC(=C/C=C/C=C(C)/C=C/C=C(C)/C=C/C1C(=C)CCCC1(C)C)C=CC=C(/C)C=CC2C(=C)CCCC2(C)C UPYKUZBSLRQECL-UKMVMLAPSA-N 0.000 description 1
- 206010025421 Macule Diseases 0.000 description 1
- 208000002038 Muscle Hypertonia Diseases 0.000 description 1
- 208000029549 Muscle injury Diseases 0.000 description 1
- 206010028851 Necrosis Diseases 0.000 description 1
- 206010028980 Neoplasm Diseases 0.000 description 1
- 208000013901 Nephropathies and tubular disease Diseases 0.000 description 1
- 241000283973 Oryctolagus cuniculus Species 0.000 description 1
- 206010033307 Overweight Diseases 0.000 description 1
- 206010033557 Palpitations Diseases 0.000 description 1
- 235000002789 Panax ginseng Nutrition 0.000 description 1
- 235000005035 Panax pseudoginseng ssp. pseudoginseng Nutrition 0.000 description 1
- 235000003140 Panax quinquefolius Nutrition 0.000 description 1
- 208000031481 Pathologic Constriction Diseases 0.000 description 1
- QGMRQYFBGABWDR-UHFFFAOYSA-M Pentobarbital sodium Chemical compound [Na+].CCCC(C)C1(CC)C(=O)NC(=O)[N-]C1=O QGMRQYFBGABWDR-UHFFFAOYSA-M 0.000 description 1
- 235000010627 Phaseolus vulgaris Nutrition 0.000 description 1
- 244000046052 Phaseolus vulgaris Species 0.000 description 1
- OAICVXFJPJFONN-UHFFFAOYSA-N Phosphorus Chemical compound [P] OAICVXFJPJFONN-UHFFFAOYSA-N 0.000 description 1
- 241000013557 Plantaginaceae Species 0.000 description 1
- 206010036618 Premenstrual syndrome Diseases 0.000 description 1
- 241000245063 Primula Species 0.000 description 1
- 235000016311 Primula vulgaris Nutrition 0.000 description 1
- 235000011158 Prunus mume Nutrition 0.000 description 1
- 244000018795 Prunus mume Species 0.000 description 1
- 206010038001 Rebound effect Diseases 0.000 description 1
- 208000004680 Rectal Fistula Diseases 0.000 description 1
- 241000405414 Rehmannia Species 0.000 description 1
- 206010038372 Renal arteriosclerosis Diseases 0.000 description 1
- QNVSXXGDAPORNA-UHFFFAOYSA-N Resveratrol Natural products OC1=CC=CC(C=CC=2C=C(O)C(O)=CC=2)=C1 QNVSXXGDAPORNA-UHFFFAOYSA-N 0.000 description 1
- 241000657665 Rhopilema esculentum Species 0.000 description 1
- 241000447727 Scabies Species 0.000 description 1
- 102000007562 Serum Albumin Human genes 0.000 description 1
- 108010071390 Serum Albumin Proteins 0.000 description 1
- 241000208292 Solanaceae Species 0.000 description 1
- 101000693619 Starmerella bombicola Lactone esterase Proteins 0.000 description 1
- 241000282894 Sus scrofa domesticus Species 0.000 description 1
- 229930183118 Tanshinone Natural products 0.000 description 1
- FEWJPZIEWOKRBE-UHFFFAOYSA-N Tartaric acid Natural products [H+].[H+].[O-]C(=O)C(O)C(O)C([O-])=O FEWJPZIEWOKRBE-UHFFFAOYSA-N 0.000 description 1
- 241000130764 Tinea Species 0.000 description 1
- 208000002474 Tinea Diseases 0.000 description 1
- 206010053476 Traumatic haemorrhage Diseases 0.000 description 1
- 208000012886 Vertigo Diseases 0.000 description 1
- 229930003268 Vitamin C Natural products 0.000 description 1
- 206010047700 Vomiting Diseases 0.000 description 1
- 206010048245 Yellow skin Diseases 0.000 description 1
- 230000002159 abnormal effect Effects 0.000 description 1
- 231100000215 acute (single dose) toxicity testing Toxicity 0.000 description 1
- 238000011047 acute toxicity test Methods 0.000 description 1
- 239000002671 adjuvant Substances 0.000 description 1
- 210000004100 adrenal gland Anatomy 0.000 description 1
- 230000002411 adverse Effects 0.000 description 1
- 208000037883 airway inflammation Diseases 0.000 description 1
- 230000000172 allergic effect Effects 0.000 description 1
- BJEPYKJPYRNKOW-UHFFFAOYSA-N alpha-hydroxysuccinic acid Natural products OC(=O)C(O)CC(O)=O BJEPYKJPYRNKOW-UHFFFAOYSA-N 0.000 description 1
- 229960000711 alprostadil Drugs 0.000 description 1
- 230000003321 amplification Effects 0.000 description 1
- 206010002156 anal fistula Diseases 0.000 description 1
- 238000004458 analytical method Methods 0.000 description 1
- 230000008485 antagonism Effects 0.000 description 1
- 239000003242 anti bacterial agent Substances 0.000 description 1
- 230000003712 anti-aging effect Effects 0.000 description 1
- 230000003266 anti-allergic effect Effects 0.000 description 1
- 230000002421 anti-septic effect Effects 0.000 description 1
- 230000000259 anti-tumor effect Effects 0.000 description 1
- 229940088710 antibiotic agent Drugs 0.000 description 1
- 230000003078 antioxidant effect Effects 0.000 description 1
- 239000002221 antipyretic Substances 0.000 description 1
- 230000036506 anxiety Effects 0.000 description 1
- 230000006793 arrhythmia Effects 0.000 description 1
- 206010003119 arrhythmia Diseases 0.000 description 1
- 210000001367 artery Anatomy 0.000 description 1
- 238000003556 assay Methods 0.000 description 1
- QVGXLLKOCUKJST-UHFFFAOYSA-N atomic oxygen Chemical compound [O] QVGXLLKOCUKJST-UHFFFAOYSA-N 0.000 description 1
- 230000037444 atrophy Effects 0.000 description 1
- 230000000680 avirulence Effects 0.000 description 1
- 230000003542 behavioural effect Effects 0.000 description 1
- 238000012742 biochemical analysis Methods 0.000 description 1
- 230000004071 biological effect Effects 0.000 description 1
- 235000019658 bitter taste Nutrition 0.000 description 1
- 238000004820 blood count Methods 0.000 description 1
- 238000009835 boiling Methods 0.000 description 1
- 230000003925 brain function Effects 0.000 description 1
- 235000014121 butter Nutrition 0.000 description 1
- 229960001948 caffeine Drugs 0.000 description 1
- VJEONQKOZGKCAK-UHFFFAOYSA-N caffeine Natural products CN1C(=O)N(C)C(=O)C2=C1C=CN2C VJEONQKOZGKCAK-UHFFFAOYSA-N 0.000 description 1
- 239000011575 calcium Substances 0.000 description 1
- 229910052791 calcium Inorganic materials 0.000 description 1
- 239000002775 capsule Substances 0.000 description 1
- 230000023852 carbohydrate metabolic process Effects 0.000 description 1
- 235000021256 carbohydrate metabolism Nutrition 0.000 description 1
- 235000014633 carbohydrates Nutrition 0.000 description 1
- 230000000747 cardiac effect Effects 0.000 description 1
- 235000005473 carotenes Nutrition 0.000 description 1
- 150000001746 carotenes Chemical class 0.000 description 1
- 210000005056 cell body Anatomy 0.000 description 1
- 230000005779 cell damage Effects 0.000 description 1
- 208000037887 cell injury Diseases 0.000 description 1
- 229920002678 cellulose Polymers 0.000 description 1
- 239000001913 cellulose Substances 0.000 description 1
- 210000003169 central nervous system Anatomy 0.000 description 1
- 230000008859 change Effects 0.000 description 1
- 231100000132 chronic toxicity testing Toxicity 0.000 description 1
- 229950001002 cianidanol Drugs 0.000 description 1
- 210000000589 cicatrix Anatomy 0.000 description 1
- 235000019504 cigarettes Nutrition 0.000 description 1
- 235000015165 citric acid Nutrition 0.000 description 1
- 238000004140 cleaning Methods 0.000 description 1
- 229920001436 collagen Polymers 0.000 description 1
- 239000002131 composite material Substances 0.000 description 1
- 239000004567 concrete Substances 0.000 description 1
- 239000000470 constituent Substances 0.000 description 1
- 239000008162 cooking oil Substances 0.000 description 1
- 208000026758 coronary atherosclerosis Diseases 0.000 description 1
- MDZKJHQSJHYOHJ-UHFFFAOYSA-N crataegolic acid Natural products C1C(O)C(O)C(C)(C)C2CCC3(C)C4(C)CCC5(C(O)=O)CCC(C)(C)CC5C4=CCC3C21C MDZKJHQSJHYOHJ-UHFFFAOYSA-N 0.000 description 1
- 235000012754 curcumin Nutrition 0.000 description 1
- 229940109262 curcumin Drugs 0.000 description 1
- 239000004148 curcumin Substances 0.000 description 1
- 230000003013 cytotoxicity Effects 0.000 description 1
- 231100000135 cytotoxicity Toxicity 0.000 description 1
- 238000000354 decomposition reaction Methods 0.000 description 1
- 230000007423 decrease Effects 0.000 description 1
- 206010061428 decreased appetite Diseases 0.000 description 1
- 230000006735 deficit Effects 0.000 description 1
- VFLDPWHFBUODDF-UHFFFAOYSA-N diferuloylmethane Natural products C1=C(O)C(OC)=CC(C=CC(=O)CC(=O)C=CC=2C=C(OC)C(O)=CC=2)=C1 VFLDPWHFBUODDF-UHFFFAOYSA-N 0.000 description 1
- 230000029087 digestion Effects 0.000 description 1
- 238000007865 diluting Methods 0.000 description 1
- 238000007599 discharging Methods 0.000 description 1
- 208000016097 disease of metabolism Diseases 0.000 description 1
- 239000002552 dosage form Substances 0.000 description 1
- 230000035622 drinking Effects 0.000 description 1
- 230000009977 dual effect Effects 0.000 description 1
- 239000008157 edible vegetable oil Substances 0.000 description 1
- 235000013345 egg yolk Nutrition 0.000 description 1
- 210000002969 egg yolk Anatomy 0.000 description 1
- 230000008451 emotion Effects 0.000 description 1
- 239000000839 emulsion Substances 0.000 description 1
- 230000002124 endocrine Effects 0.000 description 1
- 210000003725 endotheliocyte Anatomy 0.000 description 1
- 229960005139 epinephrine Drugs 0.000 description 1
- 235000004626 essential fatty acids Nutrition 0.000 description 1
- 210000003414 extremity Anatomy 0.000 description 1
- 208000024756 faint Diseases 0.000 description 1
- 239000003925 fat Substances 0.000 description 1
- YMTINGFKWWXKFG-UHFFFAOYSA-N fenofibrate Chemical compound C1=CC(OC(C)(C)C(=O)OC(C)C)=CC=C1C(=O)C1=CC=C(Cl)C=C1 YMTINGFKWWXKFG-UHFFFAOYSA-N 0.000 description 1
- 229960003499 fenofibrate micronized Drugs 0.000 description 1
- 238000000855 fermentation Methods 0.000 description 1
- 230000004151 fermentation Effects 0.000 description 1
- 239000003337 fertilizer Substances 0.000 description 1
- 230000001605 fetal effect Effects 0.000 description 1
- 210000003754 fetus Anatomy 0.000 description 1
- 239000000835 fiber Substances 0.000 description 1
- 229950003499 fibrin Drugs 0.000 description 1
- 229930003944 flavone Natural products 0.000 description 1
- 150000002213 flavones Chemical class 0.000 description 1
- 235000011949 flavones Nutrition 0.000 description 1
- 235000002864 food coloring agent Nutrition 0.000 description 1
- 235000019264 food flavour enhancer Nutrition 0.000 description 1
- 230000037406 food intake Effects 0.000 description 1
- 235000012631 food intake Nutrition 0.000 description 1
- 108010074605 gamma-Globulins Proteins 0.000 description 1
- 235000008434 ginseng Nutrition 0.000 description 1
- 210000002601 glomerular mesangium Anatomy 0.000 description 1
- 150000002333 glycines Chemical class 0.000 description 1
- 229940096919 glycogen Drugs 0.000 description 1
- 229930182470 glycoside Natural products 0.000 description 1
- 230000005484 gravity Effects 0.000 description 1
- 230000026781 habituation Effects 0.000 description 1
- 230000035876 healing Effects 0.000 description 1
- 230000007407 health benefit Effects 0.000 description 1
- 230000004217 heart function Effects 0.000 description 1
- 208000014617 hemorrhoid Diseases 0.000 description 1
- 230000023597 hemostasis Effects 0.000 description 1
- 231100000753 hepatic injury Toxicity 0.000 description 1
- 231100000283 hepatitis Toxicity 0.000 description 1
- 208000002672 hepatitis B Diseases 0.000 description 1
- 210000003494 hepatocyte Anatomy 0.000 description 1
- 235000009200 high fat diet Nutrition 0.000 description 1
- 230000003054 hormonal effect Effects 0.000 description 1
- 230000037315 hyperhidrosis Effects 0.000 description 1
- 210000003026 hypopharynx Anatomy 0.000 description 1
- 230000001976 improved effect Effects 0.000 description 1
- 239000012535 impurity Substances 0.000 description 1
- 230000002458 infectious effect Effects 0.000 description 1
- 230000008595 infiltration Effects 0.000 description 1
- 238000001764 infiltration Methods 0.000 description 1
- 238000001802 infusion Methods 0.000 description 1
- 230000005764 inhibitory process Effects 0.000 description 1
- 210000000936 intestine Anatomy 0.000 description 1
- 201000005851 intracranial arteriosclerosis Diseases 0.000 description 1
- 238000011835 investigation Methods 0.000 description 1
- 230000001788 irregular Effects 0.000 description 1
- 208000028867 ischemia Diseases 0.000 description 1
- 230000000302 ischemic effect Effects 0.000 description 1
- 210000003127 knee Anatomy 0.000 description 1
- 210000000629 knee joint Anatomy 0.000 description 1
- 150000002596 lactones Chemical class 0.000 description 1
- 210000002429 large intestine Anatomy 0.000 description 1
- 230000002045 lasting effect Effects 0.000 description 1
- 230000002475 laxative effect Effects 0.000 description 1
- 235000020997 lean meat Nutrition 0.000 description 1
- 229950008554 levamlodipine Drugs 0.000 description 1
- 208000013433 lightheadedness Diseases 0.000 description 1
- 230000000670 limiting effect Effects 0.000 description 1
- 230000003859 lipid peroxidation Effects 0.000 description 1
- 230000002366 lipolytic effect Effects 0.000 description 1
- 235000021142 long-term diet Nutrition 0.000 description 1
- 231100001252 long-term toxicity Toxicity 0.000 description 1
- 239000006210 lotion Substances 0.000 description 1
- 235000014659 low sodium diet Nutrition 0.000 description 1
- 201000007227 lymph node tuberculosis Diseases 0.000 description 1
- 210000004698 lymphocyte Anatomy 0.000 description 1
- 210000002540 macrophage Anatomy 0.000 description 1
- 206010025482 malaise Diseases 0.000 description 1
- 239000001630 malic acid Substances 0.000 description 1
- 235000011090 malic acid Nutrition 0.000 description 1
- MDZKJHQSJHYOHJ-LLICELPBSA-N maslinic acid Chemical compound C1[C@@H](O)[C@H](O)C(C)(C)[C@@H]2CC[C@@]3(C)[C@]4(C)CC[C@@]5(C(O)=O)CCC(C)(C)C[C@H]5C4=CC[C@@H]3[C@]21C MDZKJHQSJHYOHJ-LLICELPBSA-N 0.000 description 1
- 235000012054 meals Nutrition 0.000 description 1
- 230000004630 mental health Effects 0.000 description 1
- QSHDDOUJBYECFT-UHFFFAOYSA-N mercury Chemical compound [Hg] QSHDDOUJBYECFT-UHFFFAOYSA-N 0.000 description 1
- 229910052753 mercury Inorganic materials 0.000 description 1
- 210000003584 mesangial cell Anatomy 0.000 description 1
- 208000030159 metabolic disease Diseases 0.000 description 1
- 230000008558 metabolic pathway by substance Effects 0.000 description 1
- 229960004329 metformin hydrochloride Drugs 0.000 description 1
- 230000004089 microcirculation Effects 0.000 description 1
- 230000001617 migratory effect Effects 0.000 description 1
- 230000008965 mitochondrial swelling Effects 0.000 description 1
- 210000001616 monocyte Anatomy 0.000 description 1
- 210000005087 mononuclear cell Anatomy 0.000 description 1
- 210000003205 muscle Anatomy 0.000 description 1
- 208000010125 myocardial infarction Diseases 0.000 description 1
- 230000017074 necrotic cell death Effects 0.000 description 1
- 210000005036 nerve Anatomy 0.000 description 1
- 210000000653 nervous system Anatomy 0.000 description 1
- 229960002715 nicotine Drugs 0.000 description 1
- SNICXCGAKADSCV-UHFFFAOYSA-N nicotine Natural products CN1CCCC1C1=CC=CN=C1 SNICXCGAKADSCV-UHFFFAOYSA-N 0.000 description 1
- 206010029410 night sweats Diseases 0.000 description 1
- 230000036565 night sweats Effects 0.000 description 1
- 231100000252 nontoxic Toxicity 0.000 description 1
- 230000003000 nontoxic effect Effects 0.000 description 1
- 229960002748 norepinephrine Drugs 0.000 description 1
- SFLSHLFXELFNJZ-UHFFFAOYSA-N norepinephrine Natural products NCC(O)C1=CC=C(O)C(O)=C1 SFLSHLFXELFNJZ-UHFFFAOYSA-N 0.000 description 1
- 238000003199 nucleic acid amplification method Methods 0.000 description 1
- 238000001543 one-way ANOVA Methods 0.000 description 1
- 230000003647 oxidation Effects 0.000 description 1
- 238000007254 oxidation reaction Methods 0.000 description 1
- 229910052760 oxygen Inorganic materials 0.000 description 1
- 239000001301 oxygen Substances 0.000 description 1
- 230000003119 painkilling effect Effects 0.000 description 1
- 238000007427 paired t-test Methods 0.000 description 1
- 230000036961 partial effect Effects 0.000 description 1
- 230000032696 parturition Effects 0.000 description 1
- 229960002275 pentobarbital sodium Drugs 0.000 description 1
- 210000005259 peripheral blood Anatomy 0.000 description 1
- 239000011886 peripheral blood Substances 0.000 description 1
- 230000002093 peripheral effect Effects 0.000 description 1
- 150000002978 peroxides Chemical class 0.000 description 1
- 230000002085 persistent effect Effects 0.000 description 1
- 239000000575 pesticide Substances 0.000 description 1
- 239000008194 pharmaceutical composition Substances 0.000 description 1
- 230000003285 pharmacodynamic effect Effects 0.000 description 1
- 230000000144 pharmacologic effect Effects 0.000 description 1
- 239000011574 phosphorus Substances 0.000 description 1
- 229910052698 phosphorus Inorganic materials 0.000 description 1
- 230000019612 pigmentation Effects 0.000 description 1
- GMVPRGQOIOIIMI-DWKJAMRDSA-N prostaglandin E1 Chemical compound CCCCC[C@H](O)\C=C\[C@H]1[C@H](O)CC(=O)[C@@H]1CCCCCCC(O)=O GMVPRGQOIOIIMI-DWKJAMRDSA-N 0.000 description 1
- 230000002633 protecting effect Effects 0.000 description 1
- 230000009325 pulmonary function Effects 0.000 description 1
- 238000010926 purge Methods 0.000 description 1
- NIFIFKQPDTWWGU-UHFFFAOYSA-N pyrite Chemical class [Fe+2].[S-][S-] NIFIFKQPDTWWGU-UHFFFAOYSA-N 0.000 description 1
- 230000000171 quenching effect Effects 0.000 description 1
- 206010037844 rash Diseases 0.000 description 1
- 239000002994 raw material Substances 0.000 description 1
- 230000001739 rebound effect Effects 0.000 description 1
- 210000000664 rectum Anatomy 0.000 description 1
- 230000002787 reinforcement Effects 0.000 description 1
- 230000003014 reinforcing effect Effects 0.000 description 1
- 230000003716 rejuvenation Effects 0.000 description 1
- 210000005084 renal tissue Anatomy 0.000 description 1
- 235000021283 resveratrol Nutrition 0.000 description 1
- 229940016667 resveratrol Drugs 0.000 description 1
- 206010039073 rheumatoid arthritis Diseases 0.000 description 1
- 230000033764 rhythmic process Effects 0.000 description 1
- 230000000630 rising effect Effects 0.000 description 1
- 208000005687 scabies Diseases 0.000 description 1
- 208000037921 secondary disease Diseases 0.000 description 1
- 230000028327 secretion Effects 0.000 description 1
- 230000007958 sleep Effects 0.000 description 1
- 230000036578 sleeping time Effects 0.000 description 1
- 239000002002 slurry Substances 0.000 description 1
- 210000000813 small intestine Anatomy 0.000 description 1
- 230000035943 smell Effects 0.000 description 1
- 230000005586 smoking cessation Effects 0.000 description 1
- 235000011888 snacks Nutrition 0.000 description 1
- NRHMKIHPTBHXPF-TUJRSCDTSA-M sodium cholate Chemical compound [Na+].C([C@H]1C[C@H]2O)[C@H](O)CC[C@]1(C)[C@@H]1[C@@H]2[C@@H]2CC[C@H]([C@@H](CCC([O-])=O)C)[C@@]2(C)[C@@H](O)C1 NRHMKIHPTBHXPF-TUJRSCDTSA-M 0.000 description 1
- 230000005982 spleen dysfunction Effects 0.000 description 1
- 230000037351 starvation Effects 0.000 description 1
- 238000012109 statistical procedure Methods 0.000 description 1
- 238000010025 steaming Methods 0.000 description 1
- 230000036262 stenosis Effects 0.000 description 1
- 208000037804 stenosis Diseases 0.000 description 1
- 230000004206 stomach function Effects 0.000 description 1
- ZSJLQEPLLKMAKR-GKHCUFPYSA-N streptozocin Chemical compound O=NN(C)C(=O)N[C@H]1[C@@H](O)O[C@H](CO)[C@@H](O)[C@@H]1O ZSJLQEPLLKMAKR-GKHCUFPYSA-N 0.000 description 1
- 239000013589 supplement Substances 0.000 description 1
- 239000000725 suspension Substances 0.000 description 1
- 239000011975 tartaric acid Substances 0.000 description 1
- 235000002906 tartaric acid Nutrition 0.000 description 1
- 150000003505 terpenes Chemical class 0.000 description 1
- 229960000278 theophylline Drugs 0.000 description 1
- 230000017423 tissue regeneration Effects 0.000 description 1
- 230000001256 tonic effect Effects 0.000 description 1
- 239000003440 toxic substance Substances 0.000 description 1
- 239000003053 toxin Substances 0.000 description 1
- 231100000765 toxin Toxicity 0.000 description 1
- 238000012549 training Methods 0.000 description 1
- 230000009466 transformation Effects 0.000 description 1
- 150000003626 triacylglycerols Chemical class 0.000 description 1
- 208000001072 type 2 diabetes mellitus Diseases 0.000 description 1
- 210000001113 umbilicus Anatomy 0.000 description 1
- 150000003673 urethanes Chemical class 0.000 description 1
- 210000004291 uterus Anatomy 0.000 description 1
- 230000002792 vascular Effects 0.000 description 1
- 210000003556 vascular endothelial cell Anatomy 0.000 description 1
- 230000008728 vascular permeability Effects 0.000 description 1
- 210000004509 vascular smooth muscle cell Anatomy 0.000 description 1
- 230000003639 vasoconstrictive effect Effects 0.000 description 1
- 210000003462 vein Anatomy 0.000 description 1
- 231100000889 vertigo Toxicity 0.000 description 1
- 210000001835 viscera Anatomy 0.000 description 1
- 230000009978 visual deterioration Effects 0.000 description 1
- NCYCYZXNIZJOKI-UHFFFAOYSA-N vitamin A aldehyde Natural products O=CC=C(C)C=CC=C(C)C=CC1=C(C)CCCC1(C)C NCYCYZXNIZJOKI-UHFFFAOYSA-N 0.000 description 1
- 235000019154 vitamin C Nutrition 0.000 description 1
- 239000011718 vitamin C Substances 0.000 description 1
- 230000008673 vomiting Effects 0.000 description 1
- 238000010792 warming Methods 0.000 description 1
- 239000002918 waste heat Substances 0.000 description 1
- 230000037303 wrinkles Effects 0.000 description 1
- 239000009306 yunnan baiyao Substances 0.000 description 1
Landscapes
- Medicines Containing Plant Substances (AREA)
Abstract
The invention discloses health-care blood-fat-lowering evening primrose oral liquid. The oral liquid comprises, by weight, 10-50 parts of evening primrose, 10-20 parts of radix trichosanthis, 10-20 parts of hawthorn fruit, 10-20 parts of lycium bark, 10-20 parts of radix curcuma, 10-20 parts of safflower carthamus, 10-20 parts of rhizoma chuanxiong, 10-20 parts of dried radix rehmanniae, 10-20 parts of glossy privet fruit, 10-20 parts of giant knotweed rhizome, 10-20 parts of tuber fleeceflower stems, 10-20 parts of fiveleaf gynostemma herbs, 10-20 parts of semen cassiae, 10-20 parts of poria cocos, 10-20 parts of red peony roots, 10-20 parts of capillary wormwood herbs, 10-20 parts of roots of red-rooted salvia, 10-20 parts of rhizoma alismatis, 10-20 parts of pseudo-ginseng and 10-20 parts of corn stigmas. Evening primrose seeds contain 20-30% of oil which contains 70% of linoleic acid and 8-9% of essential gamma-linolenic acid of a human body. Evening primrose oil is capable of treating multiple kinds of diseases, regulating lipid materials in blood and effectively treating diseases such as coronary arterial infarction, atherosclerosis and cerebral thrombosis caused by high cholesterol and hyperlipoidemia, and can be used for treating multiple kinds of scleroses, diabetes, obesity, rheumatic arthritis, schizophrenia and the like.
Description
Technical field
The present invention relates to the medical health product containing deriving from plant, animal or raw mineral materials, Radix Oenotherae erythrosepalae health care oral liquid of particularly a kind of blood fat reducing and preparation method thereof.
Background technology
Radix Oenotherae erythrosepalae oil is the most important nutrient drug found this century.Seed oil-containing 20 ~ 30%, in oil, 70% is linoleic acid, and 8 ~ 9% is the gamma-Linolenic acid of needed by human.Radix Oenotherae erythrosepalae oil can treat various diseases, regulate lipid material in blood, the diseases such as the coronary ligation caused hypercholesterolemia, hyperlipidemia, atherosis and cerebral thrombosis have significant curative effect, also can treat multiple sclerosis, diabetes, obesity, rheumatic arthritis and schizophrenia etc., in laboratory, also find the effect that it has anticancer to grow.Utilize the anti-cardiovascular blockage of Radix Oenotherae erythrosepalae oil energy clinically, reduce this characteristic of cholesterol, make specific medicament, for prevention and cure of cardiovascular disease.
Radix Oenotherae erythrosepalae oil contains a large amount of essential fatty acid-γ-linoleic acid (GLA), and its specific activity linoleic acid is high tens times, and the disease utilizing Radix Oenotherae erythrosepalae the earliest to treat is multiple sclerosis, atopic dermatitis, rheumatic arthritis.Radix Oenotherae erythrosepalae originates in America one band, Indians have just found the medical value of Radix Oenotherae erythrosepalae before centuries, the Radix Oenotherae erythrosepalae of whole is soaked in a tepid bath, makes the plaster treatment bruise of lake shape and also it spread on wound and the dermatitis that skin surface is used for treating skin.Seed is entrained to Britain by the ship of carrying Cotton Gossypii by time ability to 18th century in the lump, also be that Europe just starts effect of Radix Oenotherae erythrosepalae to develop at this moment, many scientists, doctor drop into the research of Radix Oenotherae erythrosepalae one after another, and for multiple sclerosis, atopic dermatitis, rheumatic arthritis treatment.
Two large magical composition Radix Oenotherae erythrosepalaes of Radix Oenotherae erythrosepalae contain a large amount of necessary fatty acids and GLA: γ-linoleic acid, and Radix Oenotherae erythrosepalae of wanting to know-why has so important medical health care to be worth, and just must be familiar with these two kinds of compositions to the impact of human body.So-called " must fatty acid ", be exactly extremely important to human body, but cannot synthesizes voluntarily, must from the material of external world's picked-up, and its effect in vivo has: provide energy, maintain body temperature, protective tissue and organ; The most important thing is, it is the indispensable material of composition cells in vivo and tissue, is also the material that human body uses the important prostaglandin of synthesis and hormone, can thinks and see, if lack " necessary fatty acid ", human body can face: alopecia, and wound not easily heals.Have a strong impact on reproductive function.Immunologic function reduces, and the probability that health infects by virus and bacteria increases.
Common people naturally absorb " necessary fatty acid " from milk, vegetable seeds wet goods food, but in recent years because in the dietary sources of modern and dietary habit, undue picked-up three-hypers food: " hypercholesterolemia, higher fatty acid, high sugar content ", the source of these foods not still not nutrition, also can hinder the absorption of health to normal " necessary fatty acid ", what is called " nutrition is exaggerated " that Here it is equals the example of " malnutrition ".
In the composition of Radix Oenotherae erythrosepalae, be mainly the linoleic acid of 70%, the γ-linoleic acid of 9%, two primary categories of these two kinds " must fatty acid " just, this also explains the rationale that why Radix Oenotherae erythrosepalae is so important to human body.
In the composition of Radix Oenotherae erythrosepalae, another composition being classified as the research of medical circle focus is prostaglandin (prostagland).Nineteen thirty, the scientist of a Switzerland found this material in seminal fluid, and called after " prostaglandin ", Hou just finds prostaglandin ubiquity in human body, and has multiple different combination, and plays the synergism in different human bodies.Cite an actual example and just can know that Radix Oenotherae erythrosepalae has played the power of influence of what mystery here: the world of medicine likes being used as antiinflammatory and the formula organizing antiallergic with steroid, steroid also can reach this effect really fast, just not only side effect is large for steroid, and concerning human body, steroid suppresses " inflammatory prostaglandin " and " anti-inflammatory prostaglandin " simultaneously; The characteristic of Radix Oenotherae erythrosepalae is exactly: it can synthesize and increases " anti-inflammatory prostaglandin " but can suppress " inflammatory prostaglandin ", the biological activity of this uniqueness, makes Radix Oenotherae erythrosepalae become the formula countermeasure of more wisdom, also significantly reduces the possibility of side effect.This explains the large Gospel why Radix Oenotherae erythrosepalae may be allergic constitution patient.
In the classic of TCM of China, then Radix Oenotherae erythrosepalae is made medical herbs, be used for the treatment of in gastro-intestinal problems, asthma, cough, the healing of wound and gynaecological disease, because it is for the subduction pain of women physiological period and the secret of discomfort, just at its γ-linoleic acid be rich in and linoleic acid, energy blood vessel dilating, promotes that blood follows and nurses one's health hormone, alleviate having some setbacks and dysmenorrhoea of menstrual period, even improve climacteric obstacle.
Radix Oenotherae erythrosepalae is also known as primrose because it sees that the moon is bloomed between the lights, and daybreak namely adjust and thank, therefore named Radix Oenotherae erythrosepalae.Radix Oenotherae erythrosepalae oil takes from evening primrose seed, and be rich in GLA (gamma-Linolenic acid), gamma-Linolenic acid is a kind of essential fatty acid, self can not synthesize, must absorb from the external world in human body.It is become one to be similar to the material of hormone (PGE1) by " processing " in human body.The physiological action of gamma-Linolenic acid: endocrine regulation balances, and improves pre-menstrual syndrome, as: alleviate distending pain of the breast, irregular menstrual period, the stomachache soreness of waist etc.; Improve climacteric syndrome, as: anxiety, irritability, insomnia, giddy, perspiration etc.Improve that wrinkle increases, pigmentation, skin are yellow, black, senility and obesity problem in advance, prevent and treat allergic dermatitis.Reduce serum cholesterol and triglyceride level and suppress hematoblastic coagulation in body, preventing thrombosis.Blood vessel dilating, to reduce blood pressure, suppress rheumatoid arthritis etc.
General Radix Oenotherae erythrosepalae oil can, through heavy refining process to purify oil content, therefore, often select more cheap, low-quality or dirty oil for refining.But complicated refining process but destroys oil and a beneficial in eliminating, comprises three notes.Three notes are the natural lipophilic antioxidant contained by Radix Oenotherae erythrosepalae oil, can to free radical resisting, make the leukocyte of human body play better function, and there is antiinflammation, contribute to eliminating arthralgia.
Once eliminate these antioxidants, the oil through refine will become unstable, and is easy to cause oxidation, the toxin of the heating schedule meeting especially in refining process and then generation potentiality and carcinogenecity peroxide.
The better alternative method of producing Radix Oenotherae erythrosepalae oil adopts method for cold pressing.This process be at high pressure but low temperature squeeze the oil content of seed, therefore can guarantee that oil is stable completely, subtract protoxydic risk.
The Radix Oenotherae erythrosepalae oil produced with method for cold pressing at all without the need to through heavy refining process to purify oil content, therefore be called as the Radix Oenotherae erythrosepalae oil that " non-residual liquid " refine.Thus, the beneficial in individual-such as three notes, can be kept in oil content.
Oil content and heat, light can minimize with contacting of oxygen (destroying three large factors of oil) by the production process of cold pressing and the refining of non-residual liquid, therefore its quality can be allowed to remain on the purest native state, a natural components in simultaneously also saving-comprise three notes.
Along with growth in the living standard, the diet of people also there occurs change, and hyperlipidemia has become a kind of very common disease, and the appearance of hyperlipidemia simultaneously can cause more other diseases again, as hypertension etc.Therefore, how blood fat reducing the problem that everybody is concerned about most could have been become.Day by day flourishing due to economy, the continuous lifting of modern's living standard, cause people too much have deep love for enjoy, do not notice that the life style of oneself, behavioural habits, diet are had a liking for, thus the disease caused.Society with fast rhythm lives, the operating pressure of keen competition, serious threat is caused to the physical and mental health of modern, people more than half is made to be in sub-health state, show as: dizzy, nervous, weak, inappetence, hypomnesis, insomnia, indifferent to etc. to thing, in addition, long-term diet is unreasonable, that is: smart grain replaces coarse grain completely, a large amount of three-hypers (high heat, high protein, higher fatty acid), more than three, (antiseptic is many, flavour enhancer is many, hormone is many) pesticide residual in the absorption of food and food, chemical fertilizer stockpiling in vivo, add air, pollution of waterhead and quantity of motion less than normal, go down to make three-hypers disease (hypertension for a long time like this, hyperglycemia, hyperlipidemia), cardiovascular and cerebrovascular disease, cancers etc. so-called " modern civilization diseases " rise rapidly, and constantly rejuvenation, the serious health and lives jeopardizing the mankind." three-hypers disease " refers to hypertension, hyperglycemia (diabetes) and hyperlipidemia.Usually along with obesity.They be modern society derive from " affluenza ", can individualism, also may be interrelated.As: diabetes patient is easy to suffer from hypertension or hyperlipidemia simultaneously, and hyperlipidemia is the principal element of arteriosclerosis formation and development, and arteriosclerotic's blood vessel elasticity difference aggravation blood pressure raises, so the later stage all defines " three-hypers disease ".Be what has statistics about three-hypers, in the Chinese ten large causes of death, the mortality rate relevant to metabolic disease is just up to 35.7%, and the death toll relevant to " three-hypers " also accounts for 27% of total death toll.Hyperlipidemia can cause blood vessel embolism; Hypertension can cause cerebral hemorrhage and rupture of blood vessel in brain; Hyperglycemia can cause diabetes.
A lot of diabetes patient is with hyperlipemia, and therefore diabetes and hyperlipemia, people call that sister is sick usually, and think that hyperlipidemia is the secondary disease of diabetes.The diabetic of about 40% has disorders of lipid metabolism according to statistics.Be characterized in that triglyceride increases to reduce with high density lipoprotein.When the reason that diabetes cause blood fat to increase is due to diabetes patient's insufficient insulin, body lactonase activity lowers, and therefore easily blood fat increases.Diabetes itself also accompany fat, protein and water, dielectric disorder except carbohydrate metabolism disturbance simultaneously on the other hand.Often there is free fatty to mobilize out from fat depot, triglyceride and FFA concentrations in blood are increased.Type 2 diabetes mellitus people takes food too much on the one hand again, and motion is few, and impel lipid synthesis in body to increase, this is also the reason causing blood fat to increase.And fat companion's hyperlipidemia person, because Insulin receptor INSR number reduces relatively, thus produce insulin resistant, easy induced Diabetic.Blood fat increased perosn also easily causes the heart, cerebrovascular complication.
Chinese medicine odor is poor, and a lot of people is reluctant long-term taking; Even if take, be medicine three points of poison, allow during people's long-term taking and also produce resisting psychology.How the efficacy exertion of Radix Oenotherae erythrosepalae not being injured human body again to maximum, and obviously improve mouthfeel, people can be accepted, is our problem in the urgent need to address.
Summary of the invention
Technical problem to be solved by this invention is, current doctor trained in Western medicine has obtained larger achievement to the research of diabetic hyperlipidemia and treatment, but the hepatic and renal function caused by long-term prescription, symptom of digestive tract, after muscle damage and drug withdrawal, rebound effect is still a difficult problem for treatment.In view of the traditional Chinese medical science has the characteristic of dialectical treatmert, the advantage that Chinese medicine toxic side effect is little, Chinese medicine health-care treatment causes extensive concern.Chinese medicine also exists dual regulation, when central concentration is too high, may causes certain antagonism, and make drug effect influenced; During low dosage, possible drug level is too low, causes drug effect and does not show.And it is not good to take mouthfeel, medicine is poor, very inconvenient.Radix Oenotherae erythrosepalae oil is the most important nutrient drug found this century.Seed oil-containing 20 ~ 30%, in oil, 70% is linoleic acid, and 8 ~ 9% is the gamma-Linolenic acid of needed by human.Radix Oenotherae erythrosepalae oil can treat various diseases, regulate lipid material in blood, the diseases such as the coronary ligation caused hypercholesterolemia, hyperlipidemia, atherosis and cerebral thrombosis have significant curative effect, also can treat multiple sclerosis, diabetes, obesity, rheumatic arthritis and schizophrenia etc., in laboratory, also find the effect that it has anticancer to grow.Utilize the anti-cardiovascular blockage of Radix Oenotherae erythrosepalae oil energy clinically, reduce this characteristic of cholesterol, make specific medicament, for prevention and cure of cardiovascular disease.
For solving the problems of the technologies described above, the invention provides a kind of Radix Oenotherae erythrosepalae health care oral liquid of blood fat reducing, it is characterized in that, the parts by weight of described health care oral liquid crude drug are: Radix Oenotherae erythrosepalae 10 ~ 50 parts, Radix Trichosanthis 10 ~ 20 parts, Fructus Crataegi 10 ~ 20 parts, Cortex Lycii 10 ~ 20 parts, 10 ~ 20 parts, Rhizoma Curcumae Longae, 10 ~ 20 parts, Flos Carthami, Rhizoma Chuanxiong 10 ~ 20 parts, 10 ~ 20 parts, the Radix Rehmanniae, Fructus Ligustri Lucidi 10 ~ 20 parts, Rhizoma Polygoni Cuspidati 10 ~ 20 parts, Caulis Polygoni Multiflori 10 ~ 20 parts, Herb Gynostemmae Pentaphylli 10 ~ 20 parts, Semen Cassiae 10 ~ 20 parts, 10 ~ 20 parts, Poria, Radix Paeoniae Rubra 10 ~ 20 parts, Herba Artemisiae Scopariae 10 ~ 20 parts, Radix Salviae Miltiorrhizae 10 ~ 20 parts, Rhizoma Alismatis 10 ~ 20 parts, Radix Notoginseng 10 ~ 20 parts, Stigma Maydis 10 ~ 20 parts.
The Radix Oenotherae erythrosepalae health care oral liquid of described blood fat reducing, the parts by weight of health care oral liquid crude drug described in it can be: Radix Oenotherae erythrosepalae 10 ~ 30 parts, Radix Trichosanthis 10 ~ 15 parts, Fructus Crataegi 10 ~ 15 parts, Cortex Lycii 10 ~ 15 parts, 10 ~ 15 parts, Rhizoma Curcumae Longae, 10 ~ 15 parts, Flos Carthami, Rhizoma Chuanxiong 10 ~ 15 parts, 10 ~ 15 parts, the Radix Rehmanniae, Fructus Ligustri Lucidi 10 ~ 15 parts, Rhizoma Polygoni Cuspidati 10 ~ 15 parts, Caulis Polygoni Multiflori 10 ~ 20 parts, Herb Gynostemmae Pentaphylli 10 ~ 20 parts, Semen Cassiae 10 ~ 20 parts, 10 ~ 20 parts, Poria, Radix Paeoniae Rubra 10 ~ 20 parts, Herba Artemisiae Scopariae 10 ~ 20 parts, Radix Salviae Miltiorrhizae 10 ~ 20 parts, Rhizoma Alismatis 10 ~ 20 parts, Radix Notoginseng 10 ~ 20 parts, Stigma Maydis 10 ~ 20 parts.
The Radix Oenotherae erythrosepalae health care oral liquid of described blood fat reducing, the parts by weight of health care oral liquid crude drug described in it can also be: Radix Oenotherae erythrosepalae 10 ~ 40 parts, Radix Trichosanthis 10 ~ 20 parts, Fructus Crataegi 10 ~ 20 parts, Cortex Lycii 10 ~ 20 parts, 10 ~ 20 parts, Rhizoma Curcumae Longae, 10 ~ 20 parts, Flos Carthami, Rhizoma Chuanxiong 10 ~ 20 parts, 10 ~ 20 parts, the Radix Rehmanniae, Fructus Ligustri Lucidi 10 ~ 20 parts, Rhizoma Polygoni Cuspidati 10 ~ 20 parts, Caulis Polygoni Multiflori 10 ~ 15 parts, Herb Gynostemmae Pentaphylli 10 ~ 15 parts, Semen Cassiae 10 ~ 15 parts, 10 ~ 15 parts, Poria, Radix Paeoniae Rubra 10 ~ 15 parts, Herba Artemisiae Scopariae 10 ~ 15 parts, Radix Salviae Miltiorrhizae 10 ~ 15 parts, Rhizoma Alismatis 10 ~ 15 parts, Radix Notoginseng 10 ~ 15 parts, Stigma Maydis 10 ~ 15 parts.
For solving the problems of the technologies described above, the present invention also provides a kind of Radix Oenotherae erythrosepalae health care oral liquid of blood fat reducing, and described in it, the preparation process of Chinese medicine health-care oral liquid comprises:
A. the extraction of evening primrose seed, as component 1;
B. all the other crude drug described are put into ethanol heating and refluxing extraction 2 times, as component 2 after concentrated;
C. by add after appropriate pharmaceutical grade methylcellulose in component 1 and component also 2-in-1, add dextrin and be in harmonious proportion, after disinfection, be prepared into health oral liquor.
In described step a, can Maturity be chosen high, without insect pest, without rotting, the evening primrose seed of no-sundries; Adopt cryogenic high pressure cold pressing process, namely adopt pure physical squeezing technique, overall process is all carried out under low temperature 35 DEG C of states, collects, the Radix Oenotherae erythrosepalae oil after cold pressing as component 1.
In described step b, the medicine of all the other crude drug can be put into 10 times amount ethanol, soak 1-2 hour, heating extraction 2 times, each 1-2 hour, removes supernatant, merge extractive liquid, 100-120 order filters, then is the ultrafiltration post ultrafiltration of 5000-10000 through the molecular weight that dams, when ultrafiltrate concentrating under reduced pressure relative density is 80 DEG C 1.05 filtrate.
In described step b, may further include and the filtrate of extraction concentrated, inserted in economic benefits and social benefits vacuum concentrator, when being concentrated into 80 DEG C, relative density is the concentrated solution of 1.32, sets to 0 ~ 5 DEG C of deepfreezes 24 hours; Cold preservation liquid is added the filter aid kieselguhr of 0.3%, filter, filtrate is inserted in economic benefits and social benefits vacuum concentrator again, is concentrated into every 1ml containing 0.1g crude drug amount, becomes component 2.
In described step c, the Radix Oenotherae erythrosepalae of component 1 can be extracted oil and add appropriate pharmaceutical grade methylcellulose, blending ingredients 2, stir and add dextrin mediation, bottle after ultraviolet ray sterilization bactericidal.
For solving the problems of the technologies described above, the present invention reoffers a kind of Radix Oenotherae erythrosepalae health care oral liquid of blood fat reducing, and its preparation process can also be:
A. the high pressure low temperature cold pressing preparation of evening primrose seed, as component 1;
B. all the other crude drug described soaked, extract 3 times as component 2;
C. component 1 is added appropriate pharmaceutical grade methylcellulose and component 2 mixes, add appropriate propolis after concentrated and be in harmonious proportion, bottle after ultraviolet ray sterilization bactericidal.
In described step b, all the other crude drug can be soaked in water 12 hours, then put into extraction pot heated and boiled 1 hour, filter, filtrate is for subsequent use; Filtering residue adds water, and second time heating, boils 45 minutes, and filter, filtrate is for subsequent use; Filtering residue adds water again, heated and boiled half an hour third time, filters; Three filtrates be combined, by filtered through gauze, add 50-60% ethanol in residue, 60 DEG C-70 DEG C are continued lixiviate 2h, and every 10min stirs once, filtered through gauze, and merge lixiviating solution, being condensed into pasty state becomes component 2.
Radix Oenotherae erythrosepalae oil is the most important nutrient drug found this century.Seed oil-containing 20 ~ 30%, in oil, 70% is linoleic acid, and 8 ~ 9% is the gamma-Linolenic acid of needed by human.Radix Oenotherae erythrosepalae oil can treat various diseases, regulate lipid material in blood, the diseases such as the coronary ligation caused hypercholesterolemia, hyperlipidemia, atherosis and cerebral thrombosis have significant curative effect, also can treat multiple sclerosis, diabetes, obesity, rheumatic arthritis and schizophrenia etc., in laboratory, also find the effect that it has anticancer to grow.Utilize the anti-cardiovascular blockage of Radix Oenotherae erythrosepalae oil energy clinically, reduce this characteristic of cholesterol, make specific medicament, for prevention and cure of cardiovascular disease.Decoction is the conventional dosage forms of the traditional Chinese medical science, and it is convenient with advantages such as disease plus-minuss to have, but decoction decocting, carries, uses inconvenience, and composition is not exclusively fried, and mouthfeel is poor, is not suitable for the Modern human populations medication custom.Because the present invention is mainly used in preventing and treating hyperlipemia, hyperglycemia, this disease belongs to multifactor relevant chronic disease, and the course of disease is longer, needs long-term prescription just can reach good effect, therefore should select to take, carries, easy to usely more can improve health-care effect.Add some blood circulation promoting and blood stasis dispelling, fat and serum triglycerides are all had to the Chinese crude drug of obvious reducing effect, and can microcirculation be improved, the most mouthfeel of these medical materials is light, do not affect the taste of Radix Oenotherae erythrosepalae, make people be easy to accept, more can reach effect of blood fat reducing preferably.
Detailed description of the invention
In the blood of people, lipid contained in blood plasma is called blood fat, comprise cholesterol, cholesterol ester, triglyceride, phospholipid and not esterified fat acid etc. several.When cholesterol, triglyceride etc. all exceed normal value, be then referred to as hyperlipemia.Hyperlipemia is atherosclerotic Main Etiological Factors.Often cause serious consequence, as coronary heart disease, diabetes, cerebrovas-cularaccident, intractable hypertension and the nephrotic syndrome, pancreatitis, calculosis, fatty liver etc. because invading vitals.Arteriosclerotic generation and development, have close relationship with Hyperlipemia.Health preserving guide: one. reasonable diet is taken good care of: human body lipid comprises fat and lipoid two kinds.The relation of hyperlipemia and diet is the closest.Body fat gather the source with part lipoid, mainly from diet.Only some lipoid synthesizes in vivo, is called endogenous lipoid.It is very important for keeping on a diet to the control of hyperlipemia.Diet is advocated light, is substantially a vegetarian.But should not be a vegetarian for a long time, otherwise dietary constituents imperfection, endogenous cholesterol can be caused on the contrary to increase.Higher fatty acid, hypercholesterolemia class diet should be limited, as animal brains, egg yolk, Hepar Gallus domesticus, butter etc.Fat intake is limited in 30 ~ 50 grams every day.Carbohydrate food also will limit, and does not eat sweet food and snacks.Eat vegetable and fruit more.Suitable low salt diet, edible oil should use Oleum Glycines, Oleum Arachidis hypogaeae semen, vegetable oil, Oleum Sesami etc.Hungry full appropriateness, food-intake of often eating have dinner with next meal before half an hour have hunger sensation for degree, should not adopt starvation, excessive hunger makes body fat accelerated decomposition on the contrary, and fat acid in blood is increased.Two. definitely smoking cessation is given up alcohol: the nicotine in medicated cigarette, peripheral vessels can be made to shrink and the increase of myocardium irritability, blood pressure be raised, angina pectoris attacks.Inappropriate drinking can make Heart function fails, all has infringement to gastrointestinal tract, liver, nervous system, hormonal system, definitely should give up smoking and give up alcohol.Three. advocate and drink tea in right amount: the catechuic acid contained in Folium Camelliae sinensis has enhancing blood vessel pliability, elasticity and infiltrative effect, can prevent sclerosis of blood vessels.Theophylline in Folium Camelliae sinensis and caffeine can be excited spiritual, and blood circulation promoting, lessens fatigue and have diuresis.Drink tea in right amount and can eliminate greasy diet and lose weight.But too much drink strong tea, meeting cardiac stimulus, makes palpitating speed, is harmful to health.Four. appropriate exercise is lost weight: obesity controlling is one of important measures of prevention Hyperlipemia.Except diet control, advocate and adhere to physical training, as jogged, five mimic-animal boxing as a physical fitness exercises, taijiquan, play table tennis, disco for the elderly etc.Often participate in manual labor at ordinary times.Control the growth of body weight.
Does which hyperlipemia have endanger to patient? (1) glomerular sclerosis etc.: hyperlipemia can cause vascular endothelial cell damage and stove shape to come off, Vascular Permeability is caused to raise, plasma lipoprotein is entered and is deposited on blood vessel wall inner membrance, thereafter cause the cleaning reaction of macrophage and vascular smooth muscle cell curing and form speckle, and cause arteriosclerosis, renal arteriosclerosis, luminal stenosis, can make kidney generation ischemia, atrophy, interstitial fibers hypertrophy.If Renal vascular blocks, respective regions infarction, forms cicatrix after infarct machine.So cause glomerular sclerosis.Then can accelerate the generation of coronary atherosclerosis at kidney outward, cause coronary heart disease and increase the danger that myocardial infarction occurs patient.Equally, the arteriosclerosis at other positions then causes corresponding disease, as cerebral arteriosclerosis, cerebral infarction etc.(2) glomerular injury: hyperlipemia can cause lipid to deposit in glomerule, low density lipoprotein, LDL can activate mononuclear cell in circulation and cause monocyte infiltration in glomerule, and cause or exacerbate inflammation reaction, simultaneously the mesangial cell of glomerule, endotheliocyte all can produce activating oxygen molecule, promote lipid peroxidation, Oxided low-density lipoprotein (OX-LDL) has extremely strong cytotoxicity, causes Renal tissues damage.In addition, hyperlipemia can also cause collagen in Glomerular mesangium component *, laminin,LN and fibrin to increase, and these compositions are all directly related with glomerular sclerosis.
Does fat-reducing contribute to blood fat reducing? as everyone knows, hyperlipemia and low HDL mass formed by blood stasis are one of the most dangerous factors of arteriosclerosis, and overweight people usually merges lipometabolic exception, and along with the increase of obese degree, and more performance is obviously for hyperlipemia; On the contrary, too high blood fat, also promotes the excessive accumulation of fat simultaneously, forms vicious cycle.Moreover, people also find that the rising of blood fat has close relationship with the distribution of fat.The people such as Ji Saibai etc. (Kissebah, AH) think: " Fat Distribution according to people is classified, and can be divided into has the significant central obesity of soma fat deposit, and the obvious end of extremity slightly property is fat; Also have UBSO that above the waist athero is more and the more LBSO of lower part of the body athero.The disease such as hyperlipemia and diabetes, based on central obesity and UBSO, so take measures energetically to lose weight, contributes to reducing blood fat.Weight-reducing and lipid-lowering should based on composite treatment, comprise and use Chinese medicine dampness removing to reduce phlegm agent, high-fat diet is eaten in restriction, eat vegetable, bean product, lean meat, Carnis Gallus domesticus, Rhopilema esculenta etc. more, eat the more vegetable of cellulose as much as possible more, can reduce the absorption of enteral cholesterol, Bulbus Allii Cepae, Bulbus Allii, Auricularia, Fructus Crataegi, Lentinus Edodes have good effect for reducing fat, and cooking oil is preferably based on vegetable oil.The diet heat of limiting patient, eat sweet food less, add sharp movement, increase consumption, wine for giving off smoking, avoid hypertonicity, life is regular.
Radix Oenotherae erythrosepalae oil is the most important nutrient drug found this century.Seed oil-containing 20 ~ 30%, in oil, 70% is linoleic acid, and 8 ~ 9% is the gamma-Linolenic acid of needed by human.Radix Oenotherae erythrosepalae oil can treat various diseases, regulate lipid material in blood, the diseases such as the coronary ligation caused hypercholesterolemia, hyperlipidemia, atherosis and cerebral thrombosis have significant curative effect, also can treat multiple sclerosis, diabetes, obesity, rheumatic arthritis and schizophrenia etc., in laboratory, also find the effect that it has anticancer to grow.Utilize the anti-cardiovascular blockage of Radix Oenotherae erythrosepalae oil energy clinically, reduce this characteristic of cholesterol, make specific medicament, for prevention and cure of cardiovascular disease.
Radix Oenotherae erythrosepalae oil contains a large amount of essential fatty acid-γ-linoleic acid (GLA), and its specific activity linoleic acid is high tens times, and the disease utilizing Radix Oenotherae erythrosepalae the earliest to treat is multiple sclerosis, atopic dermatitis, rheumatic arthritis.Radix Oenotherae erythrosepalae originates in America one band, Indians have just found the medical value of Radix Oenotherae erythrosepalae before centuries, the Radix Oenotherae erythrosepalae of whole is soaked in a tepid bath, makes the plaster treatment bruise of lake shape and also it spread on wound and the dermatitis that skin surface is used for treating skin.Seed is entrained to Britain by the ship of carrying Cotton Gossypii by time ability to 18th century in the lump, also be that Europe just starts effect of Radix Oenotherae erythrosepalae to develop at this moment, many scientists, doctor drop into the research of Radix Oenotherae erythrosepalae one after another, and for multiple sclerosis, atopic dermatitis, rheumatic arthritis treatment.
Two large magical composition Radix Oenotherae erythrosepalaes of Radix Oenotherae erythrosepalae contain a large amount of necessary fatty acids and GLA: γ-linoleic acid, and Radix Oenotherae erythrosepalae of wanting to know-why has so important medical health care to be worth, and just must be familiar with these two kinds of compositions to the impact of human body.So-called " must fatty acid ", be exactly extremely important to human body, but cannot synthesizes voluntarily, must from the material of external world's picked-up, and its effect in vivo has: provide energy, maintain body temperature, protective tissue and organ; The most important thing is, it is the indispensable material of composition cells in vivo and tissue, is also the material that human body uses the important prostaglandin of synthesis and hormone, can thinks and see, if lack " necessary fatty acid ", human body can face: alopecia, and wound not easily heals.Have a strong impact on reproductive function.Immunologic function reduces, and the probability that health infects by virus and bacteria increases.
Common people naturally absorb " necessary fatty acid " from milk, vegetable seeds wet goods food, but in recent years because in the dietary sources of modern and dietary habit, undue picked-up three-hypers food: " hypercholesterolemia, higher fatty acid, high sugar content ", the source of these foods not still not nutrition, also can hinder the absorption of health to normal " necessary fatty acid ", what is called " nutrition is exaggerated " that Here it is equals the example of " malnutrition ".
In the composition of Radix Oenotherae erythrosepalae, be mainly the linoleic acid of 70%, 9%
γ-linoleic acid, two primary categories of these two kinds " must fatty acid " just, this also explains the rationale that why Radix Oenotherae erythrosepalae is so important to human body.
Fructus Crataegi is containing multivitamin, Crataegolic acid, tartaric acid, citric acid, malic acid etc., and also containing the mineral such as flavonoid, lactone, saccharide, protein, fat and calcium, phosphorus, ferrum, contained lipolytic enzyme can promote the digestion of fat food.Promote gastric secretion and increase the functions such as gastric enzyme element.The traditional Chinese medical science is thought, Fructus Crataegi has that removing food stagnancyization is stagnant, convergence effect such as dysentery relieving, activating blood circulation to dissipate blood stasis.Cure mainly the diseases such as eating accumulation, chest and diaphragm feeling of fullness, the amenorrhea of hernia blood stasis.Containing the ingredient such as mountain terpenoid and pyrite class in Fructus Crataegi, there is significant blood vessel dilating and hypotensive effect, there is the function strengthening cardiac muscle, arrhythmia, adjusting blood lipid and cholesterol level, Fructus Crataegi has effect of activating blood circulation to dissipate blood stasis, contribute to removing local congestion state, have auxiliary curative effect to traumatic injury; Flavonoid contained by Fructus Crataegi and the substance such as vitamin C, carotene block and reduce the generation of free radical, and the immunity of energy enhancing body, has anti-aging, anticancer effect; Having in Fructus Crataegi relievings asthma reduces phlegm, the composition of anti-bacteria, treatment abdominal pain diarrhea.
Radix Trichosanthis is the root of cucurbitaceous plant Chinese juniper beach wormwood, is a kind of Chinese medicine, and be clearing away heat-fire class medicine, its concrete effect is clearing away heat-fire, promoting the production of body fluid to quench thirst, and evacuation of pus is subsided a swelling.Cure mainly: control calentura thirsty, quench one's thirst, jaundice, dryness of the lung hemoptysis, carbuncle, hemorrhoid flaccidity.For treatment diabetes, conventional it and drugs for nourishing yin with the use of, to reach the effect for the treatment of both the principal and secondary aspects of a disease." book on Chinese herbal medicine converge with speech ": Radix Trichosanthis, it is hot and suffocating to move back the five internal organs, and as heart-fire is contained and dry tongue and mouth, lung-fire is contained and pharyngeal swelling sore throat, and spleen-fire is contained and dispute tooth swells, and phlegm-fire is contained and cough is not peaceful.If the side of body of liver-fire is swollen migratory arthralgia caused by wind, the hectic fever due to YIN-deficiency dysphoria with smothery sensation of kidney fire, or carbuncle is not burst, and pyretic toxicity does not fall apart, or five types of jaundice yellow skin and eye, and if if little water drenches puckery, be caused by all burning hot pent-up, phlegm-fire, falls in only this agent energy relieving stagnation, and can control it.Its property is sweet cold again, kindly can control thirsty, and control empty thirsty from tonic, control fire from the medicine of a cold nature thirsty, control yearningly strongly fragrant from gas medicine, controlling excessive thirst from blood medicine, is control thirsty key medicine also.
The Radix Rehmanniae: the Radix Rehmanniae is also Radix Rehmanniae, the fresh or dry tuber of Scrophulariaceae herbaceos perennial Radix Rehmanniae Rehmannia glutinosaLibosch..Heat clearing away, promote the production of body fluid, moisturize, laxation, removing blood stasis with potent drugs, tissue regeneration promoting, pain relieving, regulating menstruation, the incised wound stasis of blood, removing heat from blood, hemostasis; The effect of Radix Rehmanniae and Radix Rehmanniae is different.Radix Rehmanniae clearing away heat and promoting production of body fluid, can stop blooding and removing heat from blood, is often for consumption of YIN caused by febrile disease, the diseases such as haematemesis, laryngopharynx swelling and pain, crimson tongue excessive thirst, a speckle dermexanthesis and nosebleed heat.Relative to Radix Rehmanniae, Radix Rehmanniae is heat clearing and blood cooling, also can promote the production of body fluid, all right yin nourishing, is used for treatment yin asthenia generating intrinsic heat, hectic fever due to YIN-deficiency consumptive fever, crimson tongue excessive thirst, sends out the problems such as speckle dermexanthesis.The Radix Rehmanniae is cold in nature, and function is enriching yin and nourishing kidney.Not only promoting the production of body fluid to quench thirst and heat clearing and blood cooling, also have effect to metrorrhagia, menoxenia, frequent fetal movement, constipation etc., every blood system has the people of thermal burn the moon, can often take.If want to treat epidemic febrile disease, qingying decoction can be done with the Radix Rehmanniae; If the later stage for the treatment of epidemic febrile disease, because waste heat does not also disappear to the greatest extent, the Radix Rehmanniae should be used for boiling QINGHAOBIEJIATANG; In addition, contain for heat in blood poison, macule purple is black, and the serious heat of epidemic febrile disease enters the symptom of nutrient blood, can take the Sisheng Wan that the Radix Rehmanniae is made; General want YIN nourishing and the production of body fluid promoting to treat interior-heat quenches one's thirst with constipation, the once liquid soup that the Radix Rehmanniae boils should be eaten.
Fructus Ligustri Lucidi is used for the poor vision of the hepatic and renal YIN deficiency, visual deterioration, early whitening of beard and hair, soreness of waist tinnitus and fever due to yin deficiency etc.This product energy tonifying liver kidney yin, but the efficacy of a drug is gentle, slowly must get effect.Control poor vision, often join Radix Rehmanniae Preparata, Fructus Lycii is equal to use, controls early whitening of beard and hair, and often join the same use of Fructus Mori, fever due to yin deficiency, often joins Cortex Lycii.The hepatic and renal YIN deficiency, Light-headedness, seminal emission tinnitus, soreness of the waist and knees, early whitening of beard and hair, coronary heart disease, hyperlipemia, hypertension, chronic hepatitis.The protective effect research of liver is thought, Fructus Ligustri Lucidi contains oleanolic acid, to rat skin lower injection, serum glutamic pyruvic transminase can be reduced, there is obvious protective effect to the hepatic injury of Carbon Tetrachloride Induced, and can liver cell regeneration be promoted. oleanolic acid also can make triglyceride accumulation minimizing in liver, hepatocellular degeneration necrosis obviously alleviates, glycogen accumulation increases, serum γglobulin declines; Ultrastructure visible hepatocyte mitochondrial swelling and endosomal vesicle degeneration alleviate, hepatic tissue interstitial inflammation habituation
The micro-hardship of Rhizoma Polygoni Cuspidati, is slightly cold.Return liver, gallbladder, lung meridian.Function with cure mainly: heat-clearing and toxic substances removing, promoting the function of the gallbladder to alleviate jaundice, expelling wind and removing dampness, dissipating blood stasis analgesic therapy, relieving cough and resolving phlegm.For arthralgia, jaundice due to damp-heat, amenorrhea, postnatal blood stasis does not Xia , WEIJIA, cough with copious phlegm, burn due to hot liquid or fire, traumatic injury, carbuncle sore tumefacting virus.Rhizoma Polygoni Cuspidati extract has antipyretic effect.Resveratrol glycoside and pentobarbital sodium and urethanes have synergism, can obvious Sleeping Time Prolong Ed.Huzhang has convergence to scald wound, protects from infection and antiinflammation.In addition, certain density Stigma Maydis element can cause small intestinal hypermyotonia, and contractive amplitude increases, and increased dosage amount then can suppress small intestinal movable.Supplement to the Herbal: main air is between joint and blood stasis.Liquor takes it as wine." Japan hanako materia medica ": after managing property stagnant blood not under, trusted subordinate's distension.Evacuation of pus, main furuncle carbuncle poison, married woman's bruise, flutters damage blood stasis, broken pathogenic wind toxic stagnation of QI." the southern regions of the Yunnan Province book on Chinese herbal medicine ": attack all toxic swellings, only have sore throat, diuresis, walk meridians.Control five types of stranguria nebulousurine, anal fistula, carbuncle sore, married woman's leucorrhea with red and white discharge.
Herb Gynostemmae Pentaphylli finds through modern medicine study, Herb Gynostemmae Pentaphylli principle active component is polysaccharide, flavonoid, saponins and microelement kind, its effect mainly promotes body fat class substance metabolism, nutrition human body cell, there is good detoxicating, relieving inflammation effect simultaneously, be widely used in hyperlipidemia, fatty liver, obesity, constipation, insomnia, hepatitis B, the treatment of chronic airway inflammation (pharyngolaryngitis, gastroenteritis etc.) and health care.
Radix Salviae Miltiorrhizae is bitter, is slightly cold.GUIXIN, Liver Channel.Stasis-dispelling and pain-killing, promoting blood circulation to restore menstrual flow, clear away heart-fire relieving restlessness.For menoxenia, amenorrhea dysmenorrhea, lump in the abdomen, breast ventral spine pain, pyretic arthralgia pain, skin infection swells and ache, dysphoria and insomnia.For costa sternales hypochondriac pain, rheumatic arthralgia, lump in the abdomen lumps, and skin infection swells and ache, and tumbling down is grieved, menoxenia, amenorrhea dysmenorrhea, puerperal stasis of blood pain etc.Treatment costa sternales pain, lump in the abdomen caking, and menoxenia, amenorrhea dysmenorrhoea have good effect." detailed outline " carries: Radix Salviae Miltiorrhizae, and by " the sensible opinion of married woman " cloud, SIWU TANG controls gynecopathy, pays no attention to antenatal puerperal, how many through water, all can be general, and only taste Radix Salviae Miltiorrhizae falls apart, and cures mainly identical with it.Lid Radix Salviae Miltiorrhizae can break stagnated blood, and mend fresh blood, peaceful tire, fall stillborn fetus, only metrorrhagia dysentery, regulating menstruation arteries and veins.Main Compositions of Radix Salviae Miltiorrhizae TANSHINONES has blood vessel dilating, improves circulation, removes the effects such as intravascular coagulation, has effect of invigorating blood circulation trace, and can promote that liver blood circulates, be beneficial to liver cell regeneration.
Poria sweet in the mouth, light, property are put down, and are used as medicine and have the function of promoting diuresis to eliminate damp pathogen, strengthening the spleen stomach function regulating, mind tranquilizing and the heart calming.Modern medicine study: Poria energy enhancing human body immunity function, pachyman has obvious antitumor and protects the liver dirty effect.Poria slightly sweet flavor is put down, and enters the heart, lung, spleen channel.There is eliminating dampness and diuresis, invigorating the spleen and regulating the stomach, effect of mind tranquilizing and the heart calming.Can control dysuria, edema distension, phlegm retention cough with dyspnea, vomiting, malignant histocytosis, has loose bowels, seminal emission, stranguria with turbid discharge, palpitation with fear, forgetful disease such as grade.The diuretic of Poria, is reached by strong activating the spleen pulmonary function, different from the Chinese medicine of other direct diuretic.For diarrhea due to hypofunction of the spleen, leukorrhagia Poria can spleen invigorating, again can eliminating dampness by diuresis, and for having loose bowels caused by insufficiency of the spleen dysfunction of the spleen in transportation and transformation, leukorrhagia, application Poria has the effect of giving consideration to both the incidental and fundamental, the compatibilities such as normal and Radix Codonopsis, the Rhizoma Atractylodis Macrocephalae, Rhizoma Dioscoreae.Can be used as tonifying the lung spleen, control the adjuvant of the deficiency of vital energy.
Radix Paeoniae Rubra, clots absorbing, pain relieving, removing heat from blood, detumescence.Cure mainly: control the stagnant amenorrhea of the stasis of blood, hernia abdominal mass is gathered, suffer from abdominal pain, hypochondriac pain, epistaxis, dysentery, discharging fresh blood stool, conjunctival congestion, carbuncle, injury from falling down.Radix Paeoniae Rubra can purify the blood a point excess-heat, and dissipating blood stasis blood is detained.This product function is close with Cortex Moutan, therefore normal and Cortex Moutan mutual reinforcement between is for use.But the effect of Cortex Moutan clearing away heat and cooling blood is better, can purify the blood a point excess-heat, can control fever due to yin deficiency again; And Radix Paeoniae Rubra can only be used for blood system excess-heat, be good at promoting blood circulation to remove blood stasis." herbal classic ": main pathogen stomachache, except arthralgia due to stagnation of blood, broken hard long-pending, cold and heat hernia abdominal mass, pain relieving, diuresis, QI invigorating.
Caulis Polygoni Multiflori meridian distribution of property and flavor: sweet micro-hardship is flat.Nourish heart, calm the nerves, dredging collateral, dispel the wind, cure mainly: control insomnia, impairment caused by overstrain, hyperhidrosis, blood deficiency general pain, carbuncle, scrofula, wind skin ulcer scabies.The traditional Chinese medical science is thought, Caulis Polygoni Multiflori is put down nontoxic, sweet and slightly bitter taste, enters the heart, Liver Channel, has effect of tranquilizing and blood nourishing, dispelling wind and removing obstruction in the collateral, cures mainly the diseases such as deficiency of YIN insufficiency of blood, restlessness of asrhenia type and insomnia, rheumatic arthralgia, itchy skin eruption.The decoction dosage of Caulis Polygoni Multiflori is generally 10 ~ 30 grams, also can decoction being used as a lotion or smash deposited external.
Flos Carthami is warm in nature, acrid in the mouth.Function cures mainly and is applied to latus rectum of invigorating blood circulation, eliminating stasis to stop pain.For amenorrhea, dysmenorrhea, lochia, lump in the abdomen mass in the abdomen, traumatic injury." book on Chinese herbal medicine converge with speech ": Flos Carthami, the medicine of removing blood stasis, promoting the circulation of blood and blood, tune blood also.Main tire produces all kinds of diseases and ailments because blood is for suffering from, or blood is tired of bruise, and coma in silence; Or lochia robs the heart, umbilicus angina abdominis; Or drop slurry is difficult raw; Or afterbirth does not fall, dead fetus in the uterus, be all just before giving birth all cards, non-Flos Carthami can not be controlled.If puerperal blood faints, locked mouth refer to hold in the hand; Or heresy enters blood room, delirium is gone mad; Or blood is vexed interior swollen, sudden syncope with rigidity as extremely, be all puerperal all cards, non-Flos Carthami can not be determined.All as obstructed in amenorrhea and cold and heat are handed over and are done, or expired stomachache and purple black dripping, or injury from falling down and the QI and blood stasis of blood are amassed, or skin infection sufferings and swollen burst uneasy, be the card of all disharmony between QI and blood, non-Flos Carthami can not be adjusted, Flos Carthami promoting blood circulation to restore menstrual flow, reducing swelling and alleviating pain, there are inhibition thrombosis, antiinflammatory, analgesic effect, there is the vasoconstrictive effect eliminating epinephrine, norepinephrine, have " tonneau passages through which vital energy circulates " to act on.
Rhizoma Chuanxiong is a kind of Chinese medicinal plant, is usually used in blood-activating and qi-promoting, wind-expelling pain-stopping, and the pungent temperature of Rhizoma Chuanxiong is fragrant dry, walks and does not keep, can go loose, and the up mountain peak that reaches is pushed up; Enter blood system again, descendingly reach the sea of blood.Blood circulation promoting and blood stasis dispelling effect is extensive, the suitable various disease of stagnation of blood stasis; Wind-expelling pain-stopping, effectiveness is excellent, can control the diseases such as wind syndrome of head headache, rheumatic arthralgia.It is gas medicine in blood that former times people calls Rhizoma Chuanxiong, the functions such as pungent loose, the resolving depression of its residence of dangerous speech, sensible, pain relieving.
Semen Cassiae, Chinese medicine name.The dry mature seed of leguminous plant Semen Cassiae or little Semen Cassiae, have the merit of improving eyesight with it and name it.To gather autumn mature fruit, dry, lay seed, removing impurity.Semen Cassiae bitter in the mouth, sweet, one-tenth, cold nature, enters liver, kidney, large intestine channel; Loosening bowel to relieve constipation, blood fat reducing improving eyesight, treatment constipation and hyperlipidemia, hypertension.Liver heat removing and eyesight improving, diuretic relieving constipation, has laxative action, reducing blood pressure and blood fat.
Rhizoma Curcumae Longae Rhizoma Curcumae Longae energy circulation of qi promoting removing blood stasis with potent drugs, inducing menstruation to relieve menalgia.Cure mainly chest and abdomen swelling and pain, shoulder arm arthralgia pain, unbearably pained, puerperal blood pain, skin ulcer tinea onset, menoxenia, amenorrhea, traumatic injury.Yellow food colour can be extracted again; Contained curcumin can perform an analysis chemical reagent.Tang Materia Medica: main trusted subordinate ties long-pending, and chronic infectious disease is disobedient, the therapeutic method to keep the adverse QI flowing downwards, removing blood stasis, except wind heat, subduing inflammation.Power is strong in Radix Curcumae." Japan hanako materia medica ": control lump in the abdomen clot, carbuncle, logical menstruation, controls to fall and flutters blood stasis, detumescence poison; Only storm wind pain cold air, lower food.
Cortex Lycii, another name: Chinese wolfberry skin is Solanaceae, Lycium, is the root bark of Fructus Lycii Lycium chinense Mill..Can be used as medicine, there is removing heat from blood except effects such as steaming, lung heat clearing pathogenic fire reducing.Heat clearing away, removing heat from blood.Control asthenia hectic fever night sweat, lung-heat cough with asthma, spit blood, epistaxis, stranguria with blood, quenches one's thirst, hypertension, carbuncle, malignant boil." herbal classic ": " pathogen in main five, hankers quenching one's thirst, general arthralgia." " not Lu ": " main air wets, lower breast side of body gas, and exopathogenic heat is had a headache, and mends internal injury great Lao and to hiss suction, hard muscle, reinforcing YIN-essence, sharp intestine and small intestine, resistance to cold and summer-heat.″
Herba Artemisiae Scopariae is bitter, pungent, is slightly cold.Return spleen, stomach, liver, gallbladder meridian.Herba Artemisiae Scopariae clearing away heat-damp and promoting diuresis; Jaundice eliminating.Cure mainly: jaundice, dysuria, eczema pruritus, infectious jaundice type hepatitis.Deng. the effects such as pharmaceutical research has function of gallbladder promoting, liver function protecting, antipyretic, antiinflammatory, blood fat reducing, blood pressure lowering, coronary dilating.
Rhizoma Alismatis: be longer than promoting diuresis to eliminate damp pathogen, expels the heat-evil, for dysuria, and edema distension, the puckery pain of stranguria with turbid discharge, seminal emission, foot knee joint flaccidity is soft; Fry Rhizoma Alismatis, be partial to and spleen eliminating dampness by diuresis, for phlegm retention, dysentery, the vertigo.Rhizoma Alismatis, Poria, Polyporus; Three all can seep water dampness removing and inducing diuresis to remove edema, and Chang Sanzhe is with using; Right Rhizoma Alismatis is cold in nature, can expel the heat-evil, clearly mutually fire; Poria then can heart-spleen boosting, tranquilizing mind; And Polyporus, can only eliminating dampness by diuresis diuresis.Sweet in the mouth; Light; Cold in nature, return kidney; Urinary bladder channel.Function cures mainly: promoting diuresis to eliminate damp pathogen; Expel the heat-evil treating stranguria.Main dysuria; The puckery pain of pyretic stranguria; Edema distension; Have loose bowels; Dizziness due to fluid-retention; Seminal emission.
Stigma Maydis, also claims maize palpus.Medicinal record the earliest sees 1476 " the southern regions of the Yunnan Province book on Chinese herbal medicine ", and be the traditional Chinese crude drug of China, " Chinese Pharmacopoeia " records for 1977.For " Ministry of Health of the People's Republic of China's medical material standard " 1985 editions medicinal herbs most in use kinds that () includes.Stigma Maydis also known as dragon must be used for soaked drink to health benefit.Dragon must tea " mouthfeel is pretty good, drinks pleasantly sweet, economical and practical again, can do the health tea of the whole family.The patient of hyperlipidemia, hypertension, hyperglycemia has drunk, can blood fat reducing, blood pressure, blood glucose.Summer summer heat weight, dragon must tea effect of having removing heat from blood, purging heat, can remove the damp and hot gas in body.Stigma Maydis decoct has effect for reducing blood fat equally to hyperlipidemia patient, thus plays protection heart and brain, reduces the sickness rate of ischemic cardiovascular (comprising coronary heart disease and cerebral infarction).The lipid metabolism of Maize silk flavones extract to mice has obvious regulating action, and presents obvious dose-effect relationship.Chen Zhiqian Stigma Maydis coordinates certainly black soup treatment dyslipidemia patient 65 example to show, after treatment, TC, LDL-C significantly decline, and compare before and after treatment, difference all has the meaning of highly significant, and its effective percentage reaches 89.2%.Stigma Maydis has expansion peripheral blood vessel and has lasting hypotensive effect, especially the longest to the hypotensive effect persistent period of cold blooded animal, and when Stigma Maydis is with when certainly black soup share, its hypotensive effect greatly strengthens, and action time also extends to some extent." Chinese medicine voluminous dictionary " is recorded, and Popular Utilization Stigma Maydis treatment diabetes achieve good curative effect, and its fermentation preparation has the hypoglycemic activity of highly significant to rabbit.At present, studies in China is more is the blood sugar reducing function of corn silk water extract, Stigma Maydis total saponins and corn silk polysaccharide.
Radix Notoginseng is used as medicine with its root, and it is warm in nature, acrid in the mouth, has significant blood circulation promoting and blood stasis dispelling, subduing swelling and relieving pain effect, has the good reputation of " Radix Stephaniae Sinicae (Radix Stephaniae Dielsianae) ", " southern part of the country SHENCAO ".Excavating in season in winter in spring two because being everlasting, being divided into again " spring seven " and " winter seven ".Record in Qing Dynasty's pharmaceutical texts supplementary Amplifications of the Compendium of Materia Medica: " ginseng qi-tonifying the first, Radix Notoginseng enriches blood the first, taste with and merit also etc., therefore claiming Panax pseudoginseng, is the most precious person in Chinese medicine." become famous Chinese patent medicine " YUNNAN BAIYAO " at home and abroad and " Pien Tze Huang ", be namely that primary raw material is made with Radix Notoginseng.Cure mainly spitting of blood, spit blood, epistaxis, has blood in stool, metrorrhagia, traumatic hemorrhage, breast ventral spine pain, tumbling and swelling.
The specific embodiment of the invention
Specific embodiment 1: it is high that autumn chooses Maturity, without insect pest, without rotting, the Radix Oenotherae erythrosepalae fruit of no-sundries; Adopt cryogenic high pressure cold pressing process, namely adopt pure physical squeezing technique, overall process is all carried out under low temperature 35 DEG C of states, collects, the Radix Oenotherae erythrosepalae oil after cold pressing as component 1.
Then by Radix Trichosanthis, Fructus Crataegi, Cortex Lycii, Rhizoma Curcumae Longae, Flos Carthami, Rhizoma Chuanxiong, the Radix Rehmanniae, Fructus Ligustri Lucidi, Rhizoma Polygoni Cuspidati, Caulis Polygoni Multiflori, Herb Gynostemmae Pentaphylli, Semen Cassiae, Poria, Radix Paeoniae Rubra, Herba Artemisiae Scopariae, Radix Salviae Miltiorrhizae, Rhizoma Alismatis, Radix Notoginseng, Stigma Maydis; Add soak with ethanol, heating extraction 2 times, each 1-2 hour, removes supernatant, merge extractive liquid, 100-120 order filters, then is the ultrafiltration post ultrafiltration of 5000-10000 through the molecular weight that dams, when ultrafiltrate concentrating under reduced pressure relative density is 80 DEG C 1.25 filtrate, heating be concentrated into filtrate, stand for standby use.
Filtrate inserted in economic benefits and social benefits vacuum concentrator, when being concentrated into 80 DEG C, relative density is the concentrated solution of 1.32, sets to 0 ~ 5 DEG C of deepfreezes 24 hours; Cold preservation liquid is added the filter aid kieselguhr of 0.3%, filter, filtrate is inserted in economic benefits and social benefits vacuum concentrator again, is concentrated into every 1ml containing 0.1g crude drug amount as component 2; Then component 1 is added appropriate pharmaceutical grade methylcellulose and component 2 mixes, add appropriate dextrin after concentrated and be in harmonious proportion, bottle after ultraviolet ray sterilization bactericidal.
Specific embodiment 2: it is high that autumn chooses Maturity, without insect pest, without rotting, the Radix Oenotherae erythrosepalae fruit 1000g of no-sundries; Adopt cryogenic high pressure cold pressing process, namely adopt pure physical squeezing technique, overall process is all carried out under low temperature 35 DEG C of states, and collected by the Radix Oenotherae erythrosepalae oil after cold pressing, general 250g, as component 1.By Radix Trichosanthis 200g, Fructus Crataegi 200g, Cortex Lycii 200g, Rhizoma Curcumae Longae 200g, Flos Carthami 200g, Rhizoma Chuanxiong 200g, Radix Rehmanniae 200g, Fructus Ligustri Lucidi 200g, Rhizoma Polygoni Cuspidati 200g, Caulis Polygoni Multiflori 200g, Herb Gynostemmae Pentaphylli 200g, Semen Cassiae 200g, Poria 200g, Radix Paeoniae Rubra 200g, Herba Artemisiae Scopariae 200g, Radix Salviae Miltiorrhizae 200g, Rhizoma Alismatis 200g, Radix Notoginseng 200g, Stigma Maydis 200g, the medicine of all the other crude drug is put into and accounts for its quality 10 times amount ethanol, soak 1-2 hour, heating extraction 2 times, each 1-2 hour, remove supernatant, merge extractive liquid, 100-120 order filters, be the ultrafiltration post ultrafiltration of 5000-10000 again through the molecular weight that dams, when ultrafiltrate concentrating under reduced pressure relative density is 80 DEG C 1.25 filtrate, heating is concentrated into filtrate, stand for standby use, inserted in economic benefits and social benefits vacuum concentrator, when being concentrated into 80 DEG C, relative density is the concentrated solution of 1.32, sets to 0 ~ 5 DEG C of deepfreezes 24 hours, cold preservation liquid is added the filter aid kieselguhr of 0.3%, filter, filtrate is inserted in economic benefits and social benefits vacuum concentrator again, is concentrated into every 1ml containing 0.1g crude drug amount, then component 1 is added pharmaceutical grade methylcellulose and component 2 mixes, add appropriate propolis after concentrated and be in harmonious proportion, bottle after ultraviolet ray sterilization bactericidal of bottling after ultraviolet ray sterilization bactericidal.
Specific embodiment 3: it is high that autumn chooses Maturity, without insect pest, without rotting, the Radix Oenotherae erythrosepalae fruit 1500g of no-sundries; Adopt cryogenic high pressure cold pressing process, namely adopt pure physical squeezing technique, overall process is all carried out under low temperature 35 DEG C of states, and collected by the Radix Oenotherae erythrosepalae oil after cold pressing, general 350g, as component 1 stand for standby use.By all the other crude drug Radix Trichosanthis 300g, Fructus Crataegi 400g, Cortex Lycii 300g, Rhizoma Curcumae Longae 400g, Flos Carthami 500g, Rhizoma Chuanxiong 500g, Radix Rehmanniae 300g, Fructus Ligustri Lucidi 400g, Rhizoma Polygoni Cuspidati 400g, Caulis Polygoni Multiflori 300g, Herb Gynostemmae Pentaphylli 300g, Semen Cassiae 400g, Poria 300g, Radix Paeoniae Rubra 300g, Herba Artemisiae Scopariae 300g, Radix Salviae Miltiorrhizae 400g, Rhizoma Alismatis 400g, Radix Notoginseng 300g, Stigma Maydis 400g, to soak in water 12 hours, then put into extraction pot heated and boiled 1 hour, filter, filtrate is for subsequent use; Filtering residue adds water, and second time heating, boils 45 minutes, and filter, filtrate is for subsequent use; Filtering residue adds water again, heated and boiled half an hour third time, filters; Three filtrates are combined, by filtered through gauze, 50-60% ethanol is added in residue, 60 DEG C-70 DEG C are continued lixiviate 2h, and every 10min stirs once, filtered through gauze, merge lixiviating solution, be condensed into pasty state by component 1 and component 2-in-1 and after insert in economic benefits and social benefits vacuum concentrator, when being concentrated into 90 DEG C, relative density is the concentrated solution of 1.05, sets to 0 ~ 5 DEG C of deepfreezes 24 hours; Cold preservation liquid is added the filter aid kieselguhr of 0.3%, filter, filtrate is inserted in economic benefits and social benefits vacuum concentrator again, is concentrated into every 1ml containing 0.1g crude drug amount; As component 2; Then component 1 is added appropriate pharmaceutical grade methylcellulose and component 2 mixes, add appropriate propolis after concentrated and be in harmonious proportion, bottle after ultraviolet ray sterilization bactericidal of bottling after ultraviolet ray sterilization bactericidal.
Pharmacological toxicity is tested
One, test material:
(1) laboratory animal: mouse NIH, body weight 25-28g, male and female half and half; Rats Wistar body weight 130-160g, male and female half and half, the feedstuff of rat, mice is provided by Shandong medical college animal experimental center.
(2) test medicine:
1, medicine of the present invention: the oral liquid that embodiment 2 is made, applies with distilled water diluting during three batch equal amount of mixture experiments.
2, positive control medicine: JINGUI SHENQI WAN, commercially available.
Two, test method and result:
(1) get the healthy mice 80 of body weight 25-28g, female, hero half and half, is divided into four groups respectively by sex and body weight, often organizes 20.1, take medicine of the present invention for 2,3 groups, dosage is respectively 8.6g crude drug/kg/d, 6.4g crude drug/kg/d, 4.2g crude drug/kg/d, and take positive control drug JINGUI SHENQI WAN for the 4th group, dosage is 6g crude drug/kg/d, is used in conjunction 15 days.
Result of the test: 1,2,3 groups of mices obviously strengthen than 4 groups of mice sexual excitation degree, the number of copulations of 1,2,3 group of mice average every day increases by 3 times than the number of copulations of 4 groups of mices.
Result of the test shows that medicine of the present invention has obvious excitation to central nervous system, thus medicine of the present invention for adjustment human body function equilibrium, QI invigorating, enrich blood, slow down aging strengthens metabolism, neurolysis, sexual hypofunction has treatment foundation.
Animal acute toxicity test of the present invention
One, test material
(1) animal mouse NIH kind male and female half and half, body weight 20-22g, are provided by Shandong medical college Animal Lab..
(2) test medicine: the oral liquid that the present invention is made, is diluted with distilled water into suspension.
Two, test method and result:
Mice maximum tolerance determination: get healthy mice 32, male and female half and half, divided three groups within 24 hours, and only, gross weight 1.8ml, is equivalent to crude drug in whole 4.0g to each 0.6ml/ of gavage intestinal, i.e. 100g crude drug/kg/d, is equivalent to 857 times of clinical 65 kilograms of people.After mice administration routinely feedstuff within 12 days, have no animal dead and do not go out, existing toxic reaction.Therefore prove, medicine of the present invention has no side effect, and clinical practice is safe and reliable.
The long-term toxicity test for animals of pharmaceutical composition of the present invention
One, test material and method
(1) test medicine: the oral liquid that the embodiment of the present invention is made.
(2) laboratory animal, healthy rat Wistar, body weight 100-130g, 140 male and female half and half, by sex and body weight random packet, four groups, often organize 35.1, take test medicine for 2,3 groups, dosage is respectively 9.6/kg/d, 6.4/kg/d, 3.2/kg/d.4 groups contrast to the distilled water of respective volume amount, the equal gavage enteral administration of rat, often organize and be once used in conjunction 6 months, put to death half, and all death in 12 days is observed in remaining 1/2 drug withdrawal.
Two, test index
(1) general status comprises body weight, diet, emotion, movable energy.
(2) hemogram checking: red blood cell count(RBC), numeration of leukocyte, platelet count, hemogram etc., quantitative hemoglobin counts.
(3) biochemical analysis, serum albumin quantitatively, cholesterol, blood sugar quantitative.
(4) pathologic diagnosis: get half animal after experimental result and weigh, sacrificed by decapitation, gets blood, solution is treated others for earnest simultaneously, liver, kidney, lung, brain, spleen, gastrointestinal, bladder, adrenal gland do pathologic diagnosis.
Three, result of the test: show through rat chronic toxicity test, with the heavy dose of coloclysis of the present invention six months, increases the growth of rat, body weight, all has no side effect to brain, Liver and kidney function.Do not find that infringement changes to each histoorgan of rat, blood circulation, medication group compares no significant difference with matched group.Illustrate that medicine of the present invention has warming and recuperating the kidney-YANG, QI invigorating, enriches blood, slow down aging strengthens the drug effects such as metabolism, avirulence.
Pharmacodynamic experiment:
1 materials and methods
1.1 material
1.1.1 medicine oral liquid of the present invention (prepared by preparation method 2, be prepared into the reagent containing crude drug 0.2g/ml), is provided by preparation section of the court; Metformin hydrochloride (Shanghai Fahrenheit pharmacy).
1.1.2 animal Kunming mouse 96, male and female half and half, body weight (22.5 ± 2.5) g, provides by Shandong University's animal experimental center.
1.1.3 reagent and instrument streptozotocin (STZ) (SERVER company), purchased from magnificent company.Electronic balance AB204-WO type (prunus mume (sieb.) sieb.et zucc. Teller-Tuo company limited of Switzerland); Hitachi 7150 type automatic clinical chemistry analyzer (Japan).
1.2 method
1.2.1 modeling and grouping diabetes: animal is bought back, after adaptability feeds 1 week, be divided into normal non-diabetic group 8 and experimental group 40 at random, experimental group fasting 12 hours before modeling, modeling adopts the injection of STZ55mg/kg disposable celiac, within after administration 24 hours, survey blood glucose, glucose in urine, for three days on end, glucose in urine is qualitative +++ more than, blood glucose value is more than 16.5mmol/L, and continue constant person, be defined as diabetes and formed.
Modeling success mice is divided into 5 groups, the high, medium and low concentration group of model control group, metformin group, oral liquid of the present invention at random.
Hyperlipemia: animal is bought back, after adaptability feeds 1 week, be divided into normal non-hyperlipemia group 8 and experimental group 40 at random, experimental group fasting 12 hours before modeling, modeling gives more than 1 week containing 1% cholesterol, the high lipoprotein emulsion of 20% Adeps Sus domestica, 2% sodium cholate, 1% propylthio pyrimidine, every day 1 time, continuous 7 days.Modeling success mice is divided into 5 groups, the high, medium and low concentration group of model control group, metformin group, decocting liquid of the present invention at random.
1.2.2 administration and assay method Normal group and model control group (the isopyknic normal saline of ig); Metformin hydrochloride group (ig, 0.20g/kg); Oral liquid group of the present invention (ig every day decocting liquid 2.0g/kg of the present invention respectively, 3.0g/kg, 4.0g/kg).Each group of difference gastric infusion, 1 time/d, continuous 30 days.12h fasting before last administration, 2h after administration, plucks eye and gets blood, measures blood glucose and blood fat with automatic clinical chemistry analyzer.
1.2.3 all data of statistical procedures represent with "-χ ± S ", data acquisition SPSS11.5 statistical software analyzing and processing, if compare homogeneity of variance one way analysis of variance between many groups, if heterogeneity of variance rank test, compare and use paired t-test before and after in group.
2 results
As shown in Table 1, the high, medium and low concentration group of decocting liquid of the present invention all significantly can reduce the blood glucose of hyperglycemia mouse model, compares with model control group, and difference has statistical significance (P < 0.05) in 2.1 blood sugar lowering experiments.
The impact (-χ ± S) of table 1 Oral Liquid On Mice blood glucose of the present invention
Note: compare with Normal group, Δ Δ P < 0.01; Compare with model control group, * P < 0.05, * * P < 0.01; NS, normal saline.
2.3 blood fat reducing experiment as shown in Table 2, the high, medium and low concentration of oral liquid of the present invention all obviously can reduce TC, TG content of hyperlipemia mice model, compare with model control group, difference has statistical significance (P < 0.05, P < 0.01).
Table 2 the present invention is on the impact (χ ± S) of lipid of mice
Note: compare with Normal group, Δ Δ P < 0.01; Compare with model control group, * P < 0.05, * * P < 0.01; NS, normal saline.
3 discuss
In recent years, along with improving constantly of people's living standard, the disease incidence such as diabetes, coronary heart disease increases day by day.In the blood of people, lipid contained in blood plasma is called blood fat, comprise cholesterol, cholesterol ester, triglyceride, phospholipid and not esterified fat acid etc. several.When cholesterol, triglyceride etc. all exceed normal value, be then referred to as hyperlipemia.Hyperlipemia is atherosclerotic Main Etiological Factors.Often cause serious consequence, as coronary heart disease, diabetes, cerebrovas-cularaccident, intractable hypertension and the nephrotic syndrome, pancreatitis, calculosis, fatty liver etc. because invading vitals.Arteriosclerotic generation and development, have close relationship with Hyperlipemia.Chinese herbal medicine effect is stablized, few side effects, and research has the Chinese herbal medicine of hypoglycemic lipid-lowering effect, can provide more method for clinical treatment diabetes, hyperlipemia.Radix Oenotherae erythrosepalae oil is the most important nutrient drug found this century.Seed oil-containing 20 ~ 30%, in oil, 70% is linoleic acid, and 8 ~ 9% is the gamma-Linolenic acid of needed by human.Radix Oenotherae erythrosepalae oil can treat various diseases, regulate lipid material in blood, the diseases such as the coronary ligation caused hypercholesterolemia, hyperlipidemia, atherosis and cerebral thrombosis have significant curative effect, also can treat multiple sclerosis, diabetes, obesity, rheumatic arthritis and schizophrenia etc., in laboratory, also find the effect that it has anticancer to grow.Utilize the anti-cardiovascular blockage of Radix Oenotherae erythrosepalae oil energy clinically, reduce this characteristic of cholesterol, make specific medicament, for prevention and cure of cardiovascular disease.
Specific embodiment: Huan Zhenan, Lee 55 years old, is always stranded for nearly about 2 years, and total sleepy is felt, how to sleep also inadequate.In May, 2010, Physical examination found that blood pressure is very high.Check result: blood pressure: 150/100 mercury column.Body weight: 74 kilograms.Height: 168CM. blood routine examination: lymphocyte 44.5 term of reference 20-40%.Routine urianlysis: specific gravity of urine 1.030 term of reference 1.01-1.025.Protein+biochemical investigation: blood glucose 5.04 (on an empty stomach), T-CHOL 5.31 (on an empty stomach), triglyceride 4.72, HDL-C 1.54, low-density lipoprotein cholesterol 3.24.Colorful ultrasonic medical diagnosis report: hyperlipidemia, fatty liver.Once treated situation and effect: depressor of taking medicine; Levamlodipine beaylate tablets, fenofibrate micronized capsules, lose effect.Resistance is compared to Chinese medicine mouthfeel abnormal smells from the patient.Suggestion uses Radix Oenotherae erythrosepalae oral liquid of the present invention, and mouthfeel is good, Fang Yong: seed of Radix Oenotherae erythrosepalae 45g, Radix Trichosanthis 12g, Fructus Crataegi 13g, Cortex Lycii 12g, Rhizoma Curcumae Longae 13g, Flos Carthami 12g, Rhizoma Chuanxiong 13g, Radix Rehmanniae 13g, Fructus Ligustri Lucidi 12g, Rhizoma Polygoni Cuspidati 12g, Caulis Polygoni Multiflori 13g, Herb Gynostemmae Pentaphylli 12g, Semen Cassiae 13g, Poria 12g, Radix Paeoniae Rubra 13g, Herba Artemisiae Scopariae 12g, Radix Salviae Miltiorrhizae 12g, Rhizoma Alismatis 12g, Radix Notoginseng 12g, Stigma Maydis 12g, make oral liquid by embodiment method 2 to use, every day 2 times, each 1 bottle.It within 15 days, is 1 course for the treatment of.After using 2 courses for the treatment of, triglyceride levels is still too high, and suggestion diet strictly controls, eat fat, greasy food less, eat veterinary antibiotics more, increase quantity of motion, control on the basis of body weight etc., reduce taking of Western medicine, take oral liquid of the present invention and just can control.If blood pressure, blood fat are still felt not have strength, feel sleepy, the symptoms such as waist soreness, continued to take Chinese medicine oral liquid and nurse one's health a period of time after controlling ideal, recover normal.
Radix Oenotherae erythrosepalae oil is the most important nutrient drug found this century.Seed oil-containing 20 ~ 30%, in oil, 70% is linoleic acid, and 8 ~ 9% is the gamma-Linolenic acid of needed by human.Radix Oenotherae erythrosepalae oil can treat various diseases, regulate lipid material in blood, the diseases such as the coronary ligation caused hypercholesterolemia, hyperlipidemia, atherosis and cerebral thrombosis have significant curative effect, also can treat multiple sclerosis, diabetes, obesity, rheumatic arthritis and schizophrenia etc., in laboratory, also find the effect that it has anticancer to grow.Utilize the anti-cardiovascular blockage of Radix Oenotherae erythrosepalae oil energy clinically, reduce this characteristic of cholesterol, make specific medicament, for prevention and cure of cardiovascular disease.
Claims (10)
1. the Radix Oenotherae erythrosepalae health care oral liquid of a blood fat reducing, it is characterized in that, the parts by weight of described health care oral liquid crude drug comprise: Radix Oenotherae erythrosepalae 10 ~ 50 parts, Radix Trichosanthis 10 ~ 20 parts, Fructus Crataegi 10 ~ 20 parts, Cortex Lycii 10 ~ 20 parts, 10 ~ 20 parts, Rhizoma Curcumae Longae, 10 ~ 20 parts, Flos Carthami, Rhizoma Chuanxiong 10 ~ 20 parts, 10 ~ 20 parts, the Radix Rehmanniae, Fructus Ligustri Lucidi 10 ~ 20 parts, Rhizoma Polygoni Cuspidati 10 ~ 20 parts, Caulis Polygoni Multiflori 10 ~ 20 parts, Herb Gynostemmae Pentaphylli 10 ~ 20 parts, Semen Cassiae 10 ~ 20 parts, 10 ~ 20 parts, Poria, Radix Paeoniae Rubra 10 ~ 20 parts, Herba Artemisiae Scopariae 10 ~ 20 parts, Radix Salviae Miltiorrhizae 10 ~ 20 parts, Rhizoma Alismatis 10 ~ 20 parts, Radix Notoginseng 10 ~ 20 parts, Stigma Maydis 10 ~ 20 parts.
2. the Radix Oenotherae erythrosepalae health care oral liquid of blood fat reducing according to claim 1, it is characterized in that, the parts by weight of described health care oral liquid crude drug comprise: Radix Oenotherae erythrosepalae 10 ~ 30 parts, Radix Trichosanthis 10 ~ 15 parts, Fructus Crataegi 10 ~ 15 parts, Cortex Lycii 10 ~ 15 parts, 10 ~ 15 parts, Rhizoma Curcumae Longae, 10 ~ 15 parts, Flos Carthami, Rhizoma Chuanxiong 10 ~ 15 parts, 10 ~ 15 parts, the Radix Rehmanniae, Fructus Ligustri Lucidi 10 ~ 15 parts, Rhizoma Polygoni Cuspidati 10 ~ 15 parts, Caulis Polygoni Multiflori 10 ~ 20 parts, Herb Gynostemmae Pentaphylli 10 ~ 20 parts, Semen Cassiae 10 ~ 20 parts, 10 ~ 20 parts, Poria, Radix Paeoniae Rubra 10 ~ 20 parts, Herba Artemisiae Scopariae 10 ~ 20 parts, Radix Salviae Miltiorrhizae 10 ~ 20 parts, Rhizoma Alismatis 10 ~ 20 parts, Radix Notoginseng 10 ~ 20 parts, Stigma Maydis 10 ~ 20 parts.
3. the Radix Oenotherae erythrosepalae health care oral liquid of blood fat reducing according to claim 1, it is characterized in that, the parts by weight of described health care oral liquid crude drug comprise: Radix Oenotherae erythrosepalae 10 ~ 40 parts, Radix Trichosanthis 10 ~ 20 parts, Fructus Crataegi 10 ~ 20 parts, Cortex Lycii 10 ~ 20 parts, 10 ~ 20 parts, Rhizoma Curcumae Longae, 10 ~ 20 parts, Flos Carthami, Rhizoma Chuanxiong 10 ~ 20 parts, 10 ~ 20 parts, the Radix Rehmanniae, Fructus Ligustri Lucidi 10 ~ 20 parts, Rhizoma Polygoni Cuspidati 10 ~ 20 parts, Caulis Polygoni Multiflori 10 ~ 15 parts, Herb Gynostemmae Pentaphylli 10 ~ 15 parts, Semen Cassiae 10 ~ 15 parts, 10 ~ 15 parts, Poria, Radix Paeoniae Rubra 10 ~ 15 parts, Herba Artemisiae Scopariae 10 ~ 15 parts, Radix Salviae Miltiorrhizae 10 ~ 15 parts, Rhizoma Alismatis 10 ~ 15 parts, Radix Notoginseng 10 ~ 15 parts, Stigma Maydis 10 ~ 15 parts.
4. a Radix Oenotherae erythrosepalae health care oral liquid for blood fat reducing according to any one of claims 1 to 3, is characterized in that, the preparation process of described Chinese medicine health-care oral liquid comprises:
A. the extraction of Radix Oenotherae erythrosepalae, as component 1;
B. all the other crude drug described are put into ethanol heating and refluxing extraction 2 times, as component 2 after concentrated;
C. by add after pharmaceutical grade methylcellulose in component 1 and component also 2-in-1, add dextrin and be in harmonious proportion, after disinfection, be prepared into health oral liquor.
5. the preparation method of the Radix Oenotherae erythrosepalae health care oral liquid of blood fat reducing according to claim 4, is characterized in that, in described step a, chooses Maturity high, without insect pest, without rotting, and the evening primrose seed of no-sundries; Adopt cryogenic high pressure cold pressing process, namely adopt pure physical squeezing technique, overall process is all carried out under low temperature 35 DEG C of states, collects, the Radix Oenotherae erythrosepalae oil after cold pressing as component 1.
6. the preparation method of the Radix Oenotherae erythrosepalae health care oral liquid of blood fat reducing according to claim 4, it is characterized in that, in described step b, the medicine of all the other crude drug is put into 10 times amount ethanol, soak 1-2 hour, heating extraction 2 times, each 1-2 hour, removes supernatant, merge extractive liquid, 100-120 order filters, then is the ultrafiltration post ultrafiltration of 5000-10000 through the molecular weight that dams, when ultrafiltrate concentrating under reduced pressure relative density is 80 DEG C 1.05 filtrate.
7. the preparation method of the Radix Oenotherae erythrosepalae health care oral liquid of blood fat reducing according to claim 4, it is characterized in that, in described step b, comprise further and the filtrate of extraction is concentrated, inserted in economic benefits and social benefits vacuum concentrator, when being concentrated into 80 DEG C, relative density is the concentrated solution of 1.32, sets to 0 ~ 5 DEG C of deepfreezes 24 hours; Cold preservation liquid is added the filter aid kieselguhr of 0.3%, filter, filtrate is inserted in economic benefits and social benefits vacuum concentrator again, is concentrated into every 1ml containing 0.1g crude drug amount, becomes component 2.
8. the preparation method of the Radix Oenotherae erythrosepalae health care oral liquid of blood fat reducing according to claim 4, is characterized in that, in described step c, the Radix Oenotherae erythrosepalae of component 1 is extracted oil and adds appropriate pharmaceutical grade methylcellulose, blending ingredients 2, stirs and adds dextrin mediation, bottle after ultraviolet ray sterilization bactericidal.
9. blood fat reducing according to any one of claims 1 to 3 Radix Oenotherae erythrosepalae health care oral liquid a preparation method, it is characterized in that, its preparation process can also be:
A. the high pressure low temperature cold pressing preparation of evening primrose seed, as component 1;
B. all the other crude drug described soaked, extract 3 times as component 2;
C. component 1 is added pharmaceutical grade methylcellulose and component 2 mixes, add appropriate propolis after concentrated and be in harmonious proportion, bottle after ultraviolet ray sterilization bactericidal.
10. the preparation method of the Radix Oenotherae erythrosepalae health care oral liquid of blood fat reducing according to claim 9, is characterized in that, in described step b, to be soaked by all the other crude drug in water 12 hours, then put into extraction pot heated and boiled 1 hour, filter, filtrate is for subsequent use; Filtering residue adds water, and second time heating, boils 45 minutes, and filter, filtrate is for subsequent use; Filtering residue adds water again, heated and boiled half an hour third time, filters; Three filtrates be combined, by filtered through gauze, add 50-60% ethanol in residue, 60 DEG C-70 DEG C are continued lixiviate 2h, and every 10min stirs once, filtered through gauze, and merge lixiviating solution, being condensed into pasty state becomes component 2.
Priority Applications (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| CN201510430210.9A CN105012873A (en) | 2015-07-21 | 2015-07-21 | Health-care blood-fat-lowering evening primrose oral liquid and preparation method thereof |
Applications Claiming Priority (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| CN201510430210.9A CN105012873A (en) | 2015-07-21 | 2015-07-21 | Health-care blood-fat-lowering evening primrose oral liquid and preparation method thereof |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| CN105012873A true CN105012873A (en) | 2015-11-04 |
Family
ID=54403411
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| CN201510430210.9A Pending CN105012873A (en) | 2015-07-21 | 2015-07-21 | Health-care blood-fat-lowering evening primrose oral liquid and preparation method thereof |
Country Status (1)
| Country | Link |
|---|---|
| CN (1) | CN105012873A (en) |
Cited By (3)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CN107158334A (en) * | 2017-07-19 | 2017-09-15 | 贵州黔香园油脂有限公司 | A kind of tea oil oral liquid with healthcare function |
| CN107897672A (en) * | 2017-11-22 | 2018-04-13 | 安徽省东博米业有限公司 | A kind of person in middle and old age's rice with blood sugar reducing function |
| CN112057581A (en) * | 2020-09-01 | 2020-12-11 | 李琳 | Medicinal and edible dual-purpose composition for rapidly reducing blood fat and blood sugar and preparation method and application thereof |
Citations (2)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CN1686498A (en) * | 2005-04-15 | 2005-10-26 | 吴金珠 | Jiangzhitongmai Chinese medicine for treating high blood fat disease |
| CN104208302A (en) * | 2014-08-26 | 2014-12-17 | 青岛恒波仪器有限公司 | Fructus rosae laevigatae healthy oral solution for reducing blood fat and preparation method thereof |
-
2015
- 2015-07-21 CN CN201510430210.9A patent/CN105012873A/en active Pending
Patent Citations (2)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CN1686498A (en) * | 2005-04-15 | 2005-10-26 | 吴金珠 | Jiangzhitongmai Chinese medicine for treating high blood fat disease |
| CN104208302A (en) * | 2014-08-26 | 2014-12-17 | 青岛恒波仪器有限公司 | Fructus rosae laevigatae healthy oral solution for reducing blood fat and preparation method thereof |
Non-Patent Citations (1)
| Title |
|---|
| 毕勤荪: "降血脂减肥新药――月见草油软胶囊", 《江苏医药》 * |
Cited By (3)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CN107158334A (en) * | 2017-07-19 | 2017-09-15 | 贵州黔香园油脂有限公司 | A kind of tea oil oral liquid with healthcare function |
| CN107897672A (en) * | 2017-11-22 | 2018-04-13 | 安徽省东博米业有限公司 | A kind of person in middle and old age's rice with blood sugar reducing function |
| CN112057581A (en) * | 2020-09-01 | 2020-12-11 | 李琳 | Medicinal and edible dual-purpose composition for rapidly reducing blood fat and blood sugar and preparation method and application thereof |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| CN102847063B (en) | Traditional Chinese medicinal composition for treating qi and blood deficiency blood stasis type diabetic feet, and its preparation method | |
| CN104208302A (en) | Fructus rosae laevigatae healthy oral solution for reducing blood fat and preparation method thereof | |
| CN103520572B (en) | A kind of Chinese medicine composition being used for the treatment of atopic dermatitis and preparation method thereof | |
| CN103749822B (en) | A kind of fruit of glossy privet hypertension and hyperlipemia health protection tea and preparation method thereof | |
| CN105749179A (en) | Traditional Chinese medicine composition for treating metabolic syndrome | |
| CN104666579A (en) | Traditional Chinese medicine composition for treating gonarthromeningitis and preparation method of traditional Chinese medicine composition | |
| CN104758806A (en) | Decocted extract for treating coronary heart disease and preparation method thereof | |
| CN104206594A (en) | Herba Taxilli health-care tea capable of lowering blood pressure and blood lipid and preparation method thereof | |
| CN104305205A (en) | Cuscuta chinensis oral liquid for improving immunity and preparation method of cuscuta chinensis oral liquid | |
| CN104905267A (en) | Semen cassiae health oral liquid capable of decreasing blood lipid and preparation method thereof | |
| CN103749824B (en) | A kind of Herb Gynostemmae Pentaphylli blood sugar lowering blood pressure depressing health tea and preparation method thereof | |
| CN103735835A (en) | Traditional Chinese medicinal preparation for treating premature graying and preparation method thereof | |
| CN105124078A (en) | Gardenia blood-glucose-reducing and lipid-reducing healthcare tea and preparing method thereof | |
| CN108277138A (en) | A kind of health-care and nutritious wine and preparation method thereof | |
| CN106177053A (en) | A kind of Hyperglycemic health care compositions comprising leaf of Cyclocarya paliurus Iljinskaja and Pericarpium Citri Reticulatae | |
| CN103749819B (en) | Fructus Corni health protection tea of a kind of hypoglycemic and preparation method thereof | |
| CN105194421A (en) | Self-heal health-care oral solution capable of reducing blood fat and preparation method thereof | |
| CN105012873A (en) | Health-care blood-fat-lowering evening primrose oral liquid and preparation method thereof | |
| CN102846824B (en) | Traditional Chinese medicinal composition for treating cold dampness blood stasis blocking channel type diabetic feet, and its preparation method | |
| CN102178781B (en) | Chinese medicine composition for treating scrotum eczema and preparation method thereof | |
| CN103933538A (en) | Medicine for treating spleen-kidney yang deficiency type cirrhosis ascites and preparation method thereof | |
| CN103705860B (en) | A kind of Chinese medicine composition for the treatment of infant jaundice and preparation method thereof | |
| CN105394282A (en) | Radix puerariae health tea capable of reducing blood pressure, blood sugar and blood lipid | |
| CN105343593A (en) | Spica prunellae health oral liquid capable of decreasing blood pressure and blood lipid as well as preparation method of spica prunellae health oral liquid | |
| CN105943705A (en) | Traditional Chinese medicine composition for treating rheumatoid arthritis and preparation method thereof |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| C06 | Publication | ||
| PB01 | Publication | ||
| C10 | Entry into substantive examination | ||
| SE01 | Entry into force of request for substantive examination | ||
| RJ01 | Rejection of invention patent application after publication | ||
| RJ01 | Rejection of invention patent application after publication |
Application publication date: 20151104 |